Equity
-€256,642
Debts exceed assets in financial year 2025.
OncoDNA
Overview
Lifetime
13 annual accounts with figures on one time axispeak €2.1m (2025)
€2.1m▲ 72.3%
lowest -€10.4m (2023)
-€3.8m▲ €1.4m
peak €16.6m (2021)
-€256,642▼ €1.0m
€5.5m▼ 47.5%
peak 40 FTE (2017)
20.6 FTE▼ 6.4%
Board34 names since 2012all names
5 directorsSOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT and 4 others
Owners5 names in the annual accounts
17.46%FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ and 1 other
Documentsfilings and deeds
14-07-202617 days before the deadline
2025financial year
Gross margin from €1.2m to €2.1mLoss of €3.8mCapital increase · Amendment of the articles 18-04Equity from €755,741 to -€256,642Debts from €10.5m to €5.5mCash from €1.1m to €520,609
Key points
from the 2025 annual accountsLosses
-€49.3m in 13 years
Every financial year from 2013 to 2025 closed with a loss. 2023 was the heaviest.
Debts
€5.5m 105% of the balance sheet
Financial debts 62%Suppliers 23%Taxes and wages 6%Other 9%
€1.4m of the debts are secured on the company's own assets. In 2021 that was €1.4m.
Staff
20.6 FTE from 40 in 2017
Between 2017 and 2025, 49% of the full-time equivalents disappeared.
Filings
13 annual accounts since 2013
The last five annual accounts were filed 1 to 39 days before the end of the period.
Position in the sector
-4.9%
Lower solvency than 95% of companies in human health. Sector median 57.8% · 784 companies.
Total assets -54%: capital reduction
Checked score
52
Fair
Financially stronger than 4% of small companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%
Negative equity caps the score at 59.
Bankruptcy probability within 12 months
0.7% Low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).
About 7 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%lowest value
01-2025: 0.2%● unchanged vs 12-2024lowest value
02-2025: 0.2%● unchanged vs 01-2025lowest value
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.2%● unchanged vs 04-2025
06-2025: 0.2%● unchanged vs 05-2025
07-2025: 0.3%▲ +0.1 percentage points vs 06-2025
08-2025: 0.3%● unchanged vs 07-2025
09-2025: 0.3%● unchanged vs 08-2025
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.4%▲ +0.1 percentage points vs 04-2026
06-2026: 0.4%● unchanged vs 05-2026
07-2026: 0.4%● unchanged vs 06-2026
08-2026: 0.7%▲ +0.3 percentage points vs 07-2026
09-2026: 0.7%● unchanged vs 08-2026
10-2026: 0.7%● unchanged vs 09-2026
11-2026: 0.7%● unchanged vs 10-2026highest value
Financial strengthWeak
Score breakdown
raises risk
Capped at 59: negative equity
Loss of €3.8m, the second in a row (financial year 2025)
Negative equity -€256,642
lowers risk
Sector: Human health activities (NACE 86)
Figures for financial year 2025 (filed on 14-07-2026)
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 2% of them on solvency, 12% on liquidity, 1% on profitability and 0% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 598 companies had the same profile as OncoDNA has now. Each dot stands for 2 companies, two years later.
83.3%
were still trading
6.0%
stopped another way
9.4%
went bankrupt
Another 1.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of OncoDNA itself is lower: 0.7% within 12 months. It rests on far more data about OncoDNA than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 598 companies, not a prediction for OncoDNA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is tight, with a current ratio of 1.02 (0.69 in 2024), below the usual 1.5. Short-term debt is 38.6% and cash 9.9% of total assets. Equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Six signals.
lowers riskraises riskneutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year -€256,642
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
17 days early
2024
1 day early
2023
8 days early
2022
26 days early
2021
39 days early
2020
40 days early
2019
29 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 23 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ 17.46%equity €11.45bn (2025) · 2025 annual accounts of FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ
- AvH Growth Capital 9.54%equity €211.9m (2025) · 2025 annual accounts of AvH Growth Capital
- BIO.BE 4.39%score 89equity €1.5m (2025) · 2025 annual accounts of BIO.BE
Shares in 2 companies, Biosequences SLU and Integragen
Board & ownershipRecent changes
5 directors reappointed
An Herremans, Geldhof Enterprises, François Blondel, Charles-André Brouwers and Société Fédérale de Participations et d'Investissement · General meeting of 17-06-2026 · Gazette deed
Reappointment: Deloitte Réviseurs d'Entreprises (statutory auditor)
General meeting of 18-07-2025 · Gazette deed
Capital increase · Amendment of the articles
Capital from €1,604,352.01 to €2,672,435.77, 1,235,636 new shares · Capital from €2,672,435.77 to €172,435.77 · Capital from €172,435.77 to €172,444.77, 171,000 new shares · General meeting of 19-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0501631837
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| OncoDNA Charleroi | €5.3m | €2.1m | -4.9% | 20.6 |
| Cerba Path Anderlecht | €5.6m | €2.1m | 73.5% | 26.9 |
| EUROFINS FORENSICS BELGIUM Bruges | €3.3m | €3.2m | 9.2% | 24.2 |
| KLINISCH LABORATORIUM AZM Waasmunster | €4.6m | €2.3m | 35.4% | 21.8 |
| BIOMEDICAL APPLICATION OF RESEARCH IN INFECTIOUS DISEASES CONTROL Ghent | €3.7m | €1.4m | 32.5% | 8.9 |
| InnoSer België Diepenbeek | €2.1m | €3.1m | 29.7% | 27.4 |
| QUERCUS LABO Ghent | €4.5m | €2.8m | 54.3% | 24.7 |
These companies have the same main activity as OncoDNA: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €2.1m and €5.6m, founded between 1996 and 2016.
Official details
Source: KBO- Status
- Active since 29-11-2012Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Joint committee
- 330Health institutions and services · annual accounts 2025
- Establishment unit
- 2.220.215.2816041 Charleroi, since 09-07-2013
- Financial year end
- 31 December
- Peppol
- Reachable since 20-11-2025
Annual accounts 2025
- €2.1m▲ 72.3%
- ≈ €1.8mestimated
- €3.8m▼ 26.3%
- -€256,642
- €5.3m▼ 53.7%
- 20.6 FTE▼ 6.4%
- Filing
- Filed on 14-07-2026, 17 days before the end of the filing period
Companies linked to OncoDNA
Shareholders
Insights on OncoDNA
OncoDNA has existed since 2012. In 2018 the gross margin rose from €21,107 to €973,827.
The gross margin has grown every year since 2022. Solvency fell in 2025 from 6.6% to -4.9% because of the loss.
In June 2023, five directors stepped down.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
full format, filed on 14-07-2026, 17 days before the deadline€2.1m
▲ 72.3%
-€2.1m
▲ €1.4m
-€3.8m
▲ €1.4m
€39,003
▲ €2.1m
-4.9%
▼ 11.5 percentage points
1.02
▲ 0.33
The turnover shown is an estimate from the gross margin.
Turnover ≈ €1.8m. Estimated: probably between €1.7m and €2.7m.
Balance sheet
balance sheet total €5.3m on 31-12-2025What the company ownsHow it is paid for
in €m
in €m
Position in the sector
-4.9%
Lower than 95% of 784 companies in 2025.
1.02
Higher than 21% of 771 companies in 2025.
-72.0%
Lower than 95% of 776 companies in 2025.
OncoDNA
Middle half of the sector
80% of the sector
Full accounts in human health (NACE 86)
Net result: bottom quarter · Equity: bottom quarter · Balance sheet total: top quarter · Working capital: middle half · Staff: middle half
Staff
€114,892
Staff costs divided by the average number of full-time equivalents.
+1 person
people who joined
people who left
In 2025, 4 people joined and 3 left. Training hours in 2025: 12.
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||||||||
20/58 |
5.3m | 11.4m | 13.4m | 19.9m | 24.3m | 28.3m | 10.2m | 7.5m | 5.4m | 5.2m | 2.5m | 1.6m | 671,201 | |
20 |
42,373 | 62,781 | 97,923 | 73,614 | 125,541 | 201,887 | 272,304 | 255,432 | 278,570 | 240,341 | 101,926 | 8,945 | 11,926 | |
21/28 |
3.2m | 6.6m | 9.7m | 16.1m | 16.5m | 16.4m | 5.0m | 4.3m | 2.6m | 1.3m | 1.1m | 520,300 | 340,299 | |
21 |
2.3m | 3.8m | 5.1m | 6.2m | 6.6m | 6.6m | 4.8m | 3.4m | 2.1m | 1.1m | 933,878 | 490,524 | 314,391 | |
22/27 |
6,190 | 25,238 | 51,154 | 67,880 | 37,019 | 45,719 | 53,900 | 73,007 | 96,063 | 61,432 | 28,057 | 20,781 | 13,932 | |
23 |
614 | 15,120 | 29,627 | 37,082 | - | 2,040 | 6,510 | 10,188 | 9,432 | 6,971 | 9,927 | 7,599 | - | |
24 |
5,576 | 7,958 | 16,998 | 23,881 | 27,622 | 26,523 | 18,822 | 46,289 | 72,716 | 54,462 | 18,130 | 13,182 | 13,932 | |
25 |
- | - | 210 | 210 | 210 | - | - | - | - | - | - | - | - | |
26 |
- | 2,160 | 4,319 | 6,708 | 9,187 | 11,752 | 14,141 | 16,529 | 13,915 | - | - | - | - | |
28 |
846,309 | 2.7m | 4.5m | 9.9m | 9.9m | 9.8m | 176,555 | 819,548 | 356,555 | 153,895 | 50 | 50 | 50 | |
29/58 |
2.1m | 4.8m | 3.6m | 3.7m | 7.7m | 11.7m | 4.9m | 2.9m | 2.6m | 3.6m | 1.5m | 1.1m | 330,902 | |
3 |
143,861 | 119,998 | 198,317 | 108,008 | - | - | - | - | - | - | - | - | - | |
30/36 |
143,861 | 119,998 | 198,317 | 108,008 | - | - | - | - | - | - | - | - | - | |
40/41 |
1.4m | 1.8m | 1.4m | 1.4m | 1.9m | 2.1m | 2.3m | 2.0m | 1.7m | 1.4m | 771,934 | 825,059 | 250,117 | |
40 |
1.1m | 1.7m | 1.2m | 1.2m | 1.3m | 1.2m | 1.3m | 886,068 | 897,358 | 1.1m | 339,090 | 309,478 | 61,925 | |
41 |
282,097 | 74,580 | 118,191 | 165,652 | 540,933 | 912,056 | 1.0m | 1.1m | 772,283 | 223,055 | 432,844 | 515,581 | 188,192 | |
50/53 |
- | 1.7m | 500,000 | - | - | - | - | - | - | - | - | - | - | |
54/58 |
520,609 | 1.1m | 1.5m | 2.1m | 5.7m | 9.5m | 2.5m | 869,022 | 805,441 | 2.2m | 693,154 | 191,707 | 80,785 | |
490/1 |
39,497 | 82,294 | 49,818 | 114,538 | 149,881 | 129,587 | 111,449 | 52,663 | 90,462 | 50,750 | 2,887 | 61,510 | - | |
| Balance sheet: equity and liabilities | ||||||||||||||
10/49 |
5.3m | 11.4m | 13.4m | 19.9m | 24.3m | 28.3m | 10.2m | 7.5m | 5.4m | 5.2m | 2.5m | 1.6m | 671,201 | |
10/15 |
-256,642 | 755,741 | 5.8m | 10.0m | 16.6m | 15.9m | 4.5m | 30,677 | 903,937 | 2.3m | 572,571 | 6,084 | 343,524 | |
10/11 |
4.3m | 14.8m | 14.8m | 30.5m | 30.5m | 24.4m | 8.2m | 1.2m | 7.0m | 5.1m | 1.1m | 320,000 | 295,000 | |
10 |
1.6m | 14.8m | 14.8m | 30.5m | 30.5m | - | - | - | - | - | - | - | - | |
100 |
1.6m | 14.8m | 14.8m | 30.5m | 30.5m | 30.0m | 10.2m | 1.2m | 8.9m | 8.8m | 1.1m | 640,000 | 640,000 | |
101 |
- | - | - | - | - | 5.6m | 2.0m | - | 1.9m | 3.8m | - | 320,000 | 345,000 | |
11 |
2.7m | - | - | - | - | - | - | - | - | - | - | - | - | |
1100/10 |
2.7m | - | - | - | - | - | - | - | - | - | - | - | - | |
14 |
-5.6m | -15.5m | -10.4m | -22.3m | -16.2m | -10.9m | -5.5m | -2.4m | -6.8m | -3.1m | -1.1m | -650,937 | -105,610 | |
15 |
1.0m | 1.5m | 1.4m | 1.9m | 2.3m | 2.5m | 1.8m | 1.2m | 685,468 | 262,662 | 503,081 | 337,021 | 154,134 | |
16 |
- | 107,250 | 66,641 | 32,000 | 35,000 | 180,000 | 29,718 | 63,053 | 89,672 | - | - | - | - | |
160/5 |
- | 107,250 | 66,641 | 32,000 | 35,000 | 180,000 | 29,718 | 63,053 | 89,672 | - | - | - | - | |
164/5 |
- | 107,250 | 66,641 | 32,000 | 35,000 | 180,000 | 29,718 | 63,053 | 89,672 | - | - | - | - | |
17/49 |
5.5m | 10.5m | 7.5m | 9.9m | 7.7m | 12.2m | 5.6m | 7.4m | 4.4m | 3.0m | 2.0m | 1.6m | 327,678 | |
17 |
3.4m | 3.4m | 2.5m | 3.3m | 3.9m | 7.5m | 2.9m | 4.0m | 2.7m | 1.1m | 850,928 | 921,021 | - | |
170/4 |
3.4m | 3.4m | 2.5m | 3.3m | 3.9m | 7.5m | 2.9m | 4.0m | 2.7m | 1.1m | 850,928 | 921,021 | - | |
42/48 |
2.0m | 6.9m | 4.8m | 6.6m | 3.8m | 4.7m | 2.6m | 3.4m | 1.6m | 1.7m | 1.1m | 453,363 | 107,053 | |
42 |
287,838 | 4.1m | 1.7m | 3.1m | 803,555 | 727,998 | 342,351 | 355,206 | 426,081 | 341,587 | 221,416 | 145,286 | - | |
43 |
- | 50,569 | 697,979 | 705,243 | - | 918,993 | 205,687 | 1.0m | - | 7,561 | - | - | - | |
430/8 |
- | 50,569 | 697,979 | 705,243 | - | 918,993 | 205,687 | 1.0m | - | 7,561 | - | - | - | |
44 |
1.3m | 1.9m | 1.6m | 1.9m | 2.0m | 2.2m | 1.4m | 1.3m | 683,249 | 1.0m | 706,095 | 247,456 | 74,730 | |
440/4 |
1.3m | 1.9m | 1.6m | 1.9m | 2.0m | 2.2m | 1.4m | 1.3m | 683,249 | 1.0m | 706,095 | 247,456 | 74,730 | |
46 |
- | - | 107,213 | 118,585 | 101,274 | 33,688 | 40,029 | 33,922 | 16,808 | 32,632 | 59,497 | - | - | |
45 |
345,653 | 495,325 | 519,820 | 578,456 | 698,319 | 712,430 | 564,754 | 577,639 | 454,202 | 243,959 | 112,429 | 60,621 | 32,323 | |
450/3 |
3,705 | 3,298 | 4,438 | 72,333 | 65,387 | 69,437 | 49,129 | 62,818 | 4,500 | 44,808 | 16,355 | 9,875 | 3,118 | |
454/9 |
341,948 | 492,027 | 515,383 | 506,123 | 632,932 | 642,993 | 515,625 | 514,821 | 449,702 | 199,151 | 96,074 | 50,746 | 29,204 | |
47/48 |
107,966 | 292,346 | 266,204 | 223,525 | 134,587 | 37,332 | 4,567 | 40,045 | 29,848 | 80,010 | - | - | - | |
492/3 |
81,640 | 230,004 | 111,041 | 25,000 | 39,000 | 54,000 | 151,692 | 27,500 | 144,590 | 111,861 | 8,950 | 218,108 | 220,625 | |
| Income statement | ||||||||||||||
9900 |
2.1m | 1.2m | 769,457 | -439,603 | 162,823 | -578,876 | 1.7m | 973,827 | 21,107 | -297,772 | 307,375 | -75,823 | 27,677 | |
62 |
2.4m | 2.6m | 3.0m | 3.0m | 3.3m | 3.6m | 3.0m | 3.6m | 3.0m | 1.2m | 601,709 | 354,023 | 137,906 | |
630 |
1.6m | 1.6m | 1.6m | 1.5m | 196,377 | 482,611 | 427,347 | 477,909 | 529,383 | 471,564 | 173,776 | 157,236 | 88,545 | |
631/4 |
66,222 | 44,879 | 153,536 | 550,558 | 170,409 | 35,059 | 583,388 | 101,039 | 72,337 | 43,804 | - | - | - | |
635/8 |
-107,250 | 40,609 | 34,641 | -3,000 | -145,000 | 150,282 | -33,335 | -26,619 | 89,672 | - | - | - | - | |
640/8 |
305,126 | 490,005 | 1.1m | 774,315 | 774,218 | 225,470 | 106,869 | 160,392 | 76,550 | 5,110 | 1,488 | 1,196 | 381 | |
66A |
103 | - | 7,717 | 150,378 | - | - | 642,993 | - | - | - | - | - | - | |
9901 |
-2.1m | -3.5m | -5.1m | -6.4m | -4.2m | -5.1m | -2.4m | -3.3m | -3.8m | -2.0m | -469,598 | -588,278 | -199,155 | |
75/76B |
530,852 | 616,529 | 557,402 | 498,591 | 981,858 | 46,109 | 44,265 | 87,131 | 100,024 | 35,456 | 87,845 | 71,735 | 95,813 | |
75 |
530,852 | 616,529 | 529,713 | 493,617 | 652,833 | 46,109 | 44,265 | 87,131 | 100,024 | 35,456 | 87,845 | 71,735 | 95,813 | |
76B |
- | - | 27,689 | 4,974 | 329,024 | - | - | - | - | - | - | - | - | |
65/66B |
2.2m | 2.2m | 5.8m | 230,559 | 2.1m | 373,160 | 730,308 | 65,132 | 52,083 | 51,965 | 37,136 | 28,034 | 2,268 | |
65 |
305,924 | 420,933 | 360,676 | 230,559 | 256,364 | 373,160 | 87,315 | 65,132 | 52,083 | 51,965 | 37,136 | 28,034 | 2,268 | |
66B |
1.9m | 1.8m | 5.5m | - | 1.8m | - | 642,993 | - | - | - | - | - | - | |
9903 |
-3.8m | -5.1m | -10.4m | -6.1m | -5.3m | -5.4m | -3.1m | -3.3m | -3.7m | -2.0m | -418,889 | -544,577 | -105,610 | |
67/77 |
3,705 | 15,396 | 61 | 3,330 | 55 | 8,400 | 4,902 | 2,336 | 4,909 | - | 684 | 750 | - | |
9904 |
-3.8m | -5.1m | -10.4m | -6.1m | -5.3m | -5.4m | -3.1m | -3.3m | -3.7m | -2.0m | -419,573 | -545,327 | -105,610 | |
9905 |
-3.8m | -5.1m | -10.4m | -6.1m | -5.3m | -5.4m | -3.1m | -3.3m | -3.7m | -2.0m | -419,573 | -545,327 | -105,610 | |
| Appropriation of the result | ||||||||||||||
9906 |
-5.6m | -15.5m | -10.4m | -22.3m | -16.2m | -10.9m | -5.5m | -10.1m | -6.8m | -3.1m | -1.1m | -650,937 | -105,610 | |
14P |
-1.8m | -10.4m | - | -16.2m | -10.9m | - | - | - | - | - | - | - | - | |
791/2 |
- | - | - | - | - | - | - | 7.7m | - | - | - | - | - | |
| Social balance sheet | ||||||||||||||
9087 |
20.6 | 22 | 30.7 | 31.5 | 33.8 | 37.5 | 31.2 | 38.1 | 40 | 18 | 10.4 | 6.2 | 2 | |
Hours worked1013 |
35,153 | 37,359 | 51,507 | 51,894 | 57,322 | 55,254 | 51,269 | 63,062 | 68,897 | 31,046 | 18,033 | 10,534 | 3,044 | |
| Document | ||||||||||||||
The notes to these accounts have 25 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 14-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | full format | 14-07-2026 | 2026-00296980 | |
| 31-12-2024 | full format | 30-07-2025 | 2025-00331910 | |
| 31-12-2023 | full format | 23-07-2024 | 2024-00278507 | |
| 31-12-2022 | full format | 05-07-2023 | 2023-00211592 | |
| 31-12-2021 | full format | 22-06-2022 | 2022-20081999 | |
| 31-12-2020 | full format | 21-06-2021 | 2021-21900404 | |
| 31-12-2019 | full format | 02-07-2020 | 2020-25600430 | |
| 31-12-2018 | full format | 05-07-2019 | 2019-29200295 | |
| 31-12-2017 | full format | 21-06-2018 | 2018-21300413 | |
| 31-12-2016 | full format | 06-06-2017 | 2017-15600208 | |
| 31-12-2015 | full format | 11-07-2016 | 2016-29800432 | |
| 31-12-2014 | full format | 23-06-2015 | 2015-19600579 | |
| 31-12-2013 | full format | 27-06-2014 | 2014-22000211 |
Subsidies and aid
European Union 2023, 1 entry, €121,194 in total
Projects
- DIGIONE I3 - DIGITAL INFRASTRUCTURE FOR ONCOLOGY IN EUROPEEuropean Regional Development Fund, 01-11-2023 to 30-04-2026, €121,194
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -551,078 | -1.9m | -3.5m | -4.9m | -4.0m | -4.6m | -2.0m | -2.8m | -3.3m | -1.5m | -295,822 | -431,042 | -110,610 | ||
| -2.2m | -3.5m | -8.7m | -4.7m | -5.1m | -4.9m | -2.7m | -2.8m | -3.2m | -1.5m | -245,797 | -388,091 | -17,065 | ||
| 37,682 | 253,161 | 593,929 | 1.3m | 2.8m | 11.7m | 1.6m | 2.1m | 1.7m | 788,227 | 621,424 | 337,236 | 413,937 | ||
| -541,467 | -436,352 | -617,455 | -3.6m | -3.8m | 7.0m | 1.6m | 63,582 | -1.4m | 1.5m | 501,447 | 110,922 | - | ||
| 39,003 | -2.1m | -1.2m | -2.9m | 3.9m | 7.0m | 2.3m | -450,446 | 955,356 | 1.9m | 368,538 | 624,913 | 223,850 | ||
| -4.9% | 6.6% | 43.6% | 50.2% | 68.2% | 56.2% | 44.4% | 0.4% | 16.7% | 43.3% | 22.6% | 0.4% | 51.2% | ||
| 1.02 | 0.69 | 0.74 | 0.56 | 2.04 | 2.50 | 1.90 | 0.87 | 1.59 | 2.11 | 1.34 | 2.38 | 3.09 | ||
| 0.95 | 0.68 | 0.70 | 0.54 | 2.04 | 2.50 | 1.90 | 0.87 | 1.59 | 2.11 | 1.34 | 2.38 | 3.09 | ||
| - | 13.93 | 1.28 | 0.99 | 0.46 | 0.77 | 1.24 | - | 4.89 | 1.31 | 3.42 | - | 0.95 | ||
| - | -680.7% | -177.6% | -61.4% | -31.7% | -34.0% | -69.4% | - | -414.0% | -88.5% | -73.3% | - | -30.7% | ||
| -72.0% | -45.2% | -77.5% | -30.8% | -21.6% | -19.1% | -30.8% | -43.7% | -69.2% | -38.3% | -16.6% | -34.1% | -15.7% | ||
| -1.80 | -4.58 | -9.68 | -21.46 | -15.55 | - | - | - | - | - | - | - | - |
EBIT margin: not included in this filing.
Debt to equity is not shown because equity is negative. Debt divided by negative equity means nothing.
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Social balance sheet
| Item | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Employees at the balance-sheet date | - | 20 | 30 | 32 | 34 |
| full-time | - | 17 | 27 | 30 | 32 |
| part-time | - | 3 | 3 | 2 | 2 |
| in full-time equivalents | 20.4 | 19.5 | 29.5 | 31.7 | 33.6 |
| 20.6 | 22 | 30.7 | 31.5 | 33.8 | |
| On a permanent contract | 21 | 20 | 30 | 32 | 32 |
| Joined | 4 | 1 | 3 | 7 | 6 |
| Left | 3 | 11 | 5 | 9 | 7 |
| Training hours | 12 | 110 | 1,382 | 16,796 | - |
Source: social balance sheet in the 2021 to 2025 annual accounts
Securities and guarantees
on own assets and for others| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Debts secured on the company's own assets | €1.4m | €1.4m | €1.4m | €1.4m | €1.4m |
| Debts guaranteed by Belgian public bodies | €300,000 | €1.1m | €1.1m | €1.1m | €1.1m |
| €2.1m | €2.1m | €2.1m | €2.1m | €2.1m |
Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €3,798 | €1,637 | €6,135 | €53,564 | €19,158 |
| Intangible fixed assets | €33,884 | €251,525 | €527,524 | €1.3m | €2.6m |
| Financial fixed assets | - | - | €60,270 | - | €137,400 |
| €1.6m | €1.6m | €1.6m | €1.5m | €196,377 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Public contracts
1 award · 2023
Achats pré-commerciaux pour l'acquisition de services de R&D pour le développement d'une solution pour l'analyse des biopsies liquides de tumeurs solides basée sur la technologie NGS. tumeurs solides, basée sur la technologie NGS
Source: TED (Tenders Electronic Daily), Publications Office of the European Union. The values are as the buyer published them. For a framework agreement, the value is a ceiling.
Insights on OncoDNA
The operating result for 2025 is a loss of €2.1m, smaller than the loss of €3.5m in 2024.
Equity is negative. Debt (€5.5m) exceeds the balance-sheet total (€5.3m).
Large changes and their cause
- 2025 Total assets -54% on 2024. Capital reduction of €13,683,878 (Official Gazette 18-04-2025). Capital reduction of €13,683,878 (Official Gazette 18-04-2025).
Board & ownership
Board
5 directors, 1 auditor, no change since June 2026Director
appointed by deed of 16-06-2023
3-year term from 2026
also on the board of 3 other companies
Director
appointed by deed of 16-06-2023
3-year term from 2026
also on the board of 4 other companies
Director, permanent representative Guy Geldhof
appointed by deed of 16-06-2023
3-year term from 2026
Director, permanent representative François Fontaine
appointed by deed of 16-06-2023
3-year term from 2026
also on the board of 43 other companies
2 other companies bankruptStatutory auditor, permanent representative Julie Delforge
current term since 02-06-2025
3-year term from 2026
listed in the 2025 annual accounts, filed on 14-07-2026
FINADEC BV
Financial director, permanent representative Virginie De Coster
appointed by deed of 20-06-2024
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Two directors jointlydeed of 04-06-2026
Permanent representatives 3
François Fontaine
Permanent representative, for SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT
appointed by deed of 16-06-2023
Mandates through the years
34 names, the dashed line is todayFrançois BLONDEL
Director
Director
GELDHOF ENTERPRISES
Director
Director
An Herremans
Director
Director
Charles-André Brouwers
Director
Director
Deloitte Réviseurs d'Entreprises
Statutory auditor
Statutory auditor
François Degrave
Member of the executive committee
Member of the executive committee
Koenraad Eycken
Member of the executive committee
Member of the executive committee
FINADEC
Financial director
Financial director
William E. Rhodes, III
Director
Director
Bernard Courtieu
Director general
Director general
Alain Declercq
Director (not named in the articles)
Director (not named in the articles)
Innosté
Director
Director
Jean-Pol DETIFFE
Director
Director
Swisscanto (CH) Private Equity Switzerland Growth I KmGK
Director (not named in the articles)
Director (not named in the articles)
William R. "Bill" Rhodes
Director
Director
Synneo SRL
Member of the executive committee
Member of the executive committee
BIO.BE
Director
Director
INVENTURES
Director
Director
John-Eric BERTRAND
Director
Director
Jean STEPHENNE
Director
Director
Sambrinvest spin-off/spin-out
Director
Director
Ignis Consulting SARL
Daily management delegate
Daily management delegate
Grégori Ghitti
It director
It director
Jean-François Laes
Member of the executive committee
Member of the executive committee
Michelle Meijer
Sales director
Sales director
Pierre Flamant
Member of the executive committee
Member of the executive committee
Ignis Counsulting SARL
Member of the executive committee
Member of the executive committee
AMNASSEN
Director
Director
SPARAXIS
Director
Director
Jean-Michel Verhaegen
Director
Director
Philippus JANSSENS de VAREBEKE
Director
Director
Pierre LEFESVRE
Director
Director
Philippe JANSSENS de VAREBEKE
Director
Director
BoardOther functionEarlierRest of the termmandate already running before its first mentionend not dated
Mandates as a list
- SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT
- Director, appointed by deed of 12-03-2019, still in office
- François BLONDEL
- Director (not named in the articles), from 25-11-2019 to 16-06-2023
- Director, appointed by deed of 16-06-2023, still in office
- GELDHOF ENTERPRISES
- Director (not named in the articles), appointed by deed of 20-12-2019, until 16-06-2023
- Director, appointed by deed of 16-06-2023, still in office
- An Herremans
- Director, from 02-07-2021 to date
- Charles-André Brouwers
- Independent director, from 02-07-2021 to 16-06-2023
- Director, appointed by deed of 16-06-2023, still in office
- Deloitte Réviseurs d'Entreprises
- Statutory auditor, appointed by deed of 01-12-2016, still in office
- François Degrave
- Member of the executive committee, appointed by deed of 28-07-2022, still in office
- Koenraad Eycken
- Member of the executive committee, appointed by deed of 28-07-2022, still in office
- FINADEC
- Financial director, appointed by deed of 20-06-2024, still in office
- William E. Rhodes, III
- Director, until 20-08-2024
- Bernard Courtieu
- Director general, appointed by deed of 15-07-2021, until 20-06-2024
- Alain Declercq
- Director (not named in the articles), from 23-12-2020 to 16-06-2023
- Innosté
- Chair of the board, appointed by deed of 10-11-2020, ended, last mentioned on 10-11-2020
- Director, appointed by deed of 10-11-2020, until 16-06-2023
- Jean-Pol DETIFFE
- Director, appointed by deed of 14-12-2012, until 16-06-2023
- Daily management delegate, appointed by deed of 14-12-2012, until 01-09-2016
- Director general, appointed by deed of 04-07-2018, ended, last mentioned on 04-07-2018
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK
- Director (not named in the articles), from 07-02-2020 to 16-06-2023
- William R. "Bill" Rhodes
- Independent director, from 02-07-2021 to 16-06-2023
- Director, appointed by deed of 16-06-2023, no longer listed in the 2025 annual accounts
- Synneo SRL
- Member of the executive committee, until 26-08-2021
- BIO.BE
- Director, appointed by deed of 14-12-2012, until 09-08-2021
- INVENTURES
- Director, appointed by deed of 09-03-2017, until 09-08-2021
- John-Eric BERTRAND
- Director, appointed by deed of 16-09-2016, until 09-08-2021
- Jean STEPHENNE
- Director, appointed by deed of 14-12-2012, until 01-10-2020
- Chair of the board, appointed by deed of 23-09-2016, ended, last mentioned on 23-09-2016
- Director, until 18-01-2021
- Sambrinvest spin-off/spin-out
- Director, appointed by deed of 14-12-2012, until 18-01-2021
- Ignis Consulting SARL
- Daily management delegate, appointed by deed of 23-09-2016, until 01-08-2020
- Grégori Ghitti
- It director, appointed by deed of 04-07-2018, no longer listed in the 2025 annual accounts
- Jean-François Laes
- Member of the executive committee, appointed by deed of 05-05-2017, last mentioned in 2018
- Michelle Meijer
- Sales director, appointed by deed of 04-07-2018, no longer listed in the 2025 annual accounts
- Pierre Flamant
- Member of the executive committee, appointed by deed of 05-05-2017, last mentioned in 2018
- Ignis Counsulting SARL
- Member of the executive committee, appointed by deed of 05-05-2017, last mentioned in 2017
- AMNASSEN
- Chair of the board, appointed by deed of 14-12-2012, until 01-09-2016
- Chair of the board, appointed by deed of 14-12-2012, last mentioned in 2012
- Director, appointed by deed of 14-12-2012, last mentioned in 2016
- SPARAXIS
- Director, appointed by deed of 16-09-2016, no longer listed in the 2025 annual accounts
- Jean-Michel Verhaegen
- Director, appointed by deed of 14-12-2012, no longer listed in the 2025 annual accounts
- Philippus JANSSENS de VAREBEKE
- Director, from before 14-06-2016, no longer listed in the 2025 annual accounts
- Pierre LEFESVRE
- Director, appointed by deed of 14-12-2012, until 31-03-2014
- Philippe JANSSENS de VAREBEKE
- Director, appointed by deed of 14-12-2012, no longer listed in the 2025 annual accounts
Control
Shareholder
Equity €11.45bn
Profit €290.9m in 2025 (profit €315.2m in 2024)
17.46%
This company
OncoDNA
Equity -€256,642
Loss €3.8m in 2025
Capital
- Capital
- €2,672,435.77
- Shares
- 23,870,625 in the deed of 04-06-2026
- Source
- deed of 04-06-2026
Owners through the years
as the annual accounts name themOwners as a list
- FEDERALE PARTICIPATIE- EN INVESTERINGSMAATSCHAPPIJ
- AvH Growth Capital
- BIO.BE
- Carbon Spin Off / Spin Out
- INVENTURES
Source: lists of holdings in the owners' accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 04-06-2026 (in French)
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Conseil d'administration, minimum trois (3) administrateurs”“Trois ans au plus, Ils sont rééligibles”“Le conseil d'administration peut, sous sa propre responsabilité, désigner des mandataires avec le titre et les pouvoirs qu'il détermine”deed of 04-06-2026 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Thursday of Junedeed of 04-06-2026 (in French)
- Auditor ruleThe articles set how a statutory auditor is appointed and what they check.
- “Trois ans au plus, commissaires”deed of 26-06-2023 (in French)
- Dissolution ruleThe articles set when and by whom the company can be dissolved.
- “Dont elle fixe les pouvoirs et les émoluments, à moins que l'assemblée générale des actionnaires ne nomme des liquidateurs”deed of 18-04-2025 (in French)
Shareholders
7 ownersOwners 7
- Equity €11.45bn Profit of €290.9m in 2025 (profit of €315.2m in 2024)17.46%
- Equity €211.9m Loss of €23.9m in 2025 (profit of €10.7m in 2024)9.54%
- Equity €1.5m Loss of €244,508 in 2025 (loss of €725,799 in 2024) Checked score 894.39%
-
share not stated
-
share not stated
-
share not stated
-
share not stated
Former owners (2)
-
share not stated
-
share not stated
Capital transactions
Shareholders according to the deeds
Share transfer
deed of 18-04-2025 ↗
- shares transferred 214,713 shares
- shares transferred 214,713 shares
After 11 capital increases
deed of 26-06-2023 ↗
- Jean-Pol DETIFFE €61,768.67
- Sambrinvest Spin-Off /Spin-Out SA (BE 0884.341.575) €268,076.70
- AvH Growth Capital SA (BE 0434.330.168) 206,086 shares · €836,718.18
- Wallonie Entreprendre SA (BE 0793.630.244) 141,539 shares · €574,653.86
- Banque CPH SCRL (BE 0402.487.939) 74,486 shares · €302,416.67
- Société Fédérale de Participations et d’Investissement – Federale Participatie - en Investeringsmaatschappij (BE 0253.445.063) 269,893 shares · €1,095,776.52
- Vesalius Biocapital III S.C.A. SICAR 461,343 shares · €1,873,057.55
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK 192,106 shares · €779,959.59
- Verve Investment Syndicates GmbH 3,897 shares · €15,826.47
- Bernard COURTIEU 5,176 shares · €21,016.67
- Spreds Finance SA (BE 0538.839.354) 20,094 shares · €81,583.98
- INVEST4ONCODNA (BE 0739.835.925) €2
- Vinsovier SA (BE 0733.765.309) €2
- Jean-Marie HENROTIN €1
- BIO.be SA (BE 0861.738.595) €2
- INVENTURES (BE 0836.671.025) €1
Stated in the deed
deed of 26-06-2023 ↗
- Jean-Pol DETIFFE 278,538 shares
- INVEST4ONCODNA (BE 0739.835.925) 426,036 shares
- Vinsovier SA (BE 0733.765.309) 302,140 shares
- Jean-Marie HENROTIN 97,483 shares
- BIO.be SA (BE 0861.738.595) 560,801 shares
- Sambrinvest Spin-Off /Spin-Out SA (BE 0884.341.575) 512,993 shares
- Michael HERMAN 3,504 shares
- Gregori GHITTI 3,504 shares
- Jean-François LAES 6,469 shares
- INVENTURES (BE 0836.671.025) 217,391 shares
- AvH Growth Capital SA (BE 0434.330.168) 597,826 shares
- Wallonie Entreprendre SA (BE 0793.630.244) 326,087 shares
- Banque CPH SCRL (BE 0402.487.939) 271,739 shares
- Adriana TERRADEZ LAVERGNE 1,150 shares
- Pierre FLAMANT 10,869 shares
- Société Fédérale de Participations et d’Investissement – Federale Participatie - en Investeringsmaatschappij (BE 0253.445.063) 1,291,800 shares
- Vesalius Biocapital III S.C.A. SICAR 803,933 shares
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK 803,733 shares
- Verve Investment Syndicates GmbH 147,041 shares
- Future Capital AG 99,200 shares
- David WICKI-BIRCHLER 92,800 shares
- Spreds Finance SA (BE 0538.839.354)
Stated in the deed
deed of 09-08-2021 ↗
- Jean-Pol DETIFFE
- INVEST4ONCODNA
- VINSOVIER (BE 0733.765.309)
- Jean-Marie HENROTIN
- BIO.BE (BE 0861.738.595)
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575)
- Michael HERMAN
- Gregori GHITTI
- Jean-François LAES
- INVENTURES (BE 0836.671.025)
- AVH GROWTH CAPITAL (BE 0434.330.168)
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487)
- BANQUE CPH (BE 0402.487.939)
- Adriana TERRADEZ LAVERGNE
- Pierre FLAMANT
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063)
- Vesalius Biocapital III S.C.A SICAR
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK
- Verve Investment Syndicates GmbH
- Future Capital AG 99,200 shares
- David WICKI-BIRCHLER 92,800 shares
- Sambrinvest
- SRIW
- CPH
- Société Fédérale de Participation et d'Investissement
- Vesalius
- Swisscanto
After 3 capital increases
deed of 18-01-2021 ↗
- Jean-Pol DETIFFE 2,646 shares · €16,542 in kind
- VINSOVIER (BE 0733.765.309) 4,098 shares · €25,615 in kind
- BIO.BE (BE 0861.738.595) 16,393 shares · €102,458 in kind
- AVH GROWTH CAPITAL (BE 0434.330.168) 81,966 shares · €512,292 in kind
- BANQUE CPH (BE 0402.487.939) 163,933 shares · €1,024,583 in kind
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487) 245,900 shares · €1,536,875 in kind
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063) 491,800 shares · €3,073,750 in kind
- Vesalius Biocapital III S.C.A. SICAR 163,933 shares · €1,024,583 in kind
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK 163,733 shares · €1,023,333 in kind
- Verve Investment Syndicates GmbH 15,040 shares · €94,000
- Future Capital AG 19,200 shares · €120,000
- David WICKI-BIRCHLER 12,800 shares · €80,000
- INVEST4ONCODNA 23,820 shares · €148,879 in kind
Stated in the deed
deed of 18-01-2021 ↗
- Jean-Pol DETIFFE
- INVEST4ONCODNA 438,119 shares
- VINSOVIER (BE 0733.765.309) 310,195 shares
- BIO.BE (BE 0861.738.595) 576,836 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575) 790,244 shares
- Michael HERMAN 3,504 shares
- Gregori GHITTI 3,504 shares
- Jean-François LAES 6,469 shares
- INVENTURES (BE 0836.671.025) 257,668 shares
- AVH GROWTH CAPITAL (BE 0434.330.168) 798,381 shares
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487) 470,642 shares
- BANQUE CPH (BE 0402.487.939) 472,294 shares
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063) 720,000 shares
- Vesalius Biocapital III S.C.A. SICAR 640,000 shares
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK 640,000 shares
- Verve Investment Syndicates GmbH 132,001 shares
- Future Capital AG 80,000 shares
- David WICKI-BIRCHLER 80,000 shares
- Jean-Marie Henrotin
- Adriana Terradez Lavergne
- Pierre Flamant
Show 8 older mentions
After 2 capital increases
deed of 14-04-2020 ↗
- Verve Investment Syndicates GmbH 132,001 shares · €825,006.25 in cash
- Future Capital AG 80,000 shares · €500,000 in cash
- David Wicki-Birchler 80,000 shares · €500,000 in cash
- Société Fédérale de Participation et d'Investissement 320,000 shares · €2,000,000 in cash
Stated in the deed
deed of 14-04-2020 ↗
- Jean-Pol DETIFFE 282,538 shares
- INVEST4ONCODNA 438,119 shares
- VINSOVIER (BE 0733.765.309) 310,195 shares
- Jean-Marie HENROTIN 89,122 shares
- BIO.BE (BE 0861.738.595) 576,836 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575) 799,244 shares
- Michael HERMAN 3,504 shares
- Gregori GHITTI 3,504 shares
- Jean-François LAES 6,469 shares
- INVENTURES (BE 0836.671.025) 257,668 shares
- SOFINIM (BE 0434.330.168) 798,381 shares
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487) 470,642 shares
- BANQUE CPH (BE 0402.487.939) 472,294 shares
- Adriana TERRADEZ LAVERGNE 1,150 shares
- BUSINESS INNOVATION S.L. 8,361 shares
- Pierre FLAMANT 10,869 shares
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063) 400,000 shares
- Vesalius Biocapital III S.C.A. SICAR 640,000 shares
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK 640,000 shares
- Verve Investment Syndicates GmbH
- Future Capital AG
- David Wicki-Birchler
After the capital increase
deed of 05-03-2020 ↗
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK 640,000 shares · €2,000,000
- BANQUE CPH (BE 0402.487.939) 120,000 shares · €375,000
- SOFINIM (BE 0434.330.168) 120,000 shares · €375,000
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575) 196,696 shares · €614,675
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487) 64,000 shares · €200,000
Stated in the deed
deed of 20-12-2019 ↗
- Jean-Pol DETIFFE 282,538 shares
- INVEST4ONCODNA 438,119 shares
- VINSOVIER (BE 0733.765.309) 310,195 shares
- Jean-Marie HENROTIN 89,122 shares
- BIO.BE (BE 0861.738.595) 576,836 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575) 593,548 shares
- Michael HERMAN 3,504 shares
- Gregori GHITTI 3,504 shares
- Jean-François LAES 6,469 shares
- INVENTURES (BE 0836.671.025) 257,668 shares
- SOFINIM (BE 0434.330.168) 678,381 shares
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487) 406,642 shares
- BANQUE CPH (BE 0402.487.939) 352,294 shares
- Adriana TERRADEZ LAVERGNE 1,150 shares
- BUSINESS INNOVATION S.L. 8,361 shares
- Pierre FLAMANT 10,869 shares
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063) 400,000 shares
- Sambrinvest 593,548 shares
- SRIW 406,642 shares
- Adrana Terradez Lavergne 1,150 shares
- Vesalius Biocapital III S.C.A. SICAR 640,000 shares
After 2 capital increases
deed of 12-03-2019 ↗
- BANQUE CPH (BE 0402.487.939) 80,555 shares · €503,472.22
- INVENTURES (BE 0836.671.025) 40,277 shares · €251,736.11
- INVEST4ONCODNA 12,083 shares · €75,520.83
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575) 80,555 shares · €503,472.22
- SOFINIM (BE 0434.330.168) 80,555 shares · €503,472.22
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE (BE 0219.919.487) 80,555 shares · €503,472.22
- VINSOVIER 8,055 shares · €50,347.22
- BIO.BE (BE 0861.738.595) 16,035 shares · €100,222.22
- Jean-Pol DETIFFE 4,000 shares · €25,000
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (BE 0253.445.063) 400,000 shares · €2,500,000
After 3 capital increases
deed of 09-03-2017 ↗
- BUSINESS INNOVATION S.L. 8,361 shares
- Adriana TERRADEZ LAVERGNE 1,150 shares
- Pierre FLAMANT 10,869 shares
After the capital increase
deed of 18-01-2016 ↗
- Jean-Pol DETIFFE 1,953 shares
- Michaël HERMAN 254 shares
- Gregori GHITTI 254 shares
- Jean-Francois LAES 469 shares
- Invest4OncoDNA 29,297 shares
- SCDC VINSOVIER 19,531 shares
- Jean-Marie HENROTIN 4,883 shares
- BIO.BE 39,062 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT 29,297 shares
At incorporation
deed of 14-12-2012 ↗
- Jean-Pol DETIFFE 100 shares (1.6%)
- Pierre LEFESVRE 50 shares (0.8%)
- INVEST4ONCODNA 1,500 shares (23.4%)
- Jean STEPHENNE 1,000 shares (15.6%)
- Jean-Marie HENROTIN 250 shares (3.9%)
- BIO.BE (BE 0861.738.595) 2,000 shares (31.2%)
- SAMBRINVEST SPIN-OFF/SPIN-OUT (BE 0884.341.575) 1,500 shares (23.4%)
Capital over time
- 04-06-2026 Capital increase of €1,068,083.76 · to €2,672,435.77 · 1,235,636 new shares at €0.86 per share · in cash
- 04-06-2026 Capital reduction of €2,500,000 · to €172,435.77 · to absorb losses
- 04-06-2026 Capital increase of €9 · to €172,444.77 · 171,000 new shares, 0.7% of the 23,870,625 shares after the increase · “exercice de droits de souscription anti-dilutifs”
- 18-04-2025 Capital reduction of €13,683,878.26 · to €1,104,337.01 · to absorb losses
- 18-04-2025 Capital increase of €500,000 · to €1,604,337.01 · 3,731,365 new shares · in kind
- 18-04-2025 Capital increase of €15 · to €1,604,352.01 · 6,053,627 new shares, 26.9% of the 22,463,989 shares after the increase · in cash
- 18-04-2025 Capital reduction of €13,683,878.26 · to €1,104,337.01 · to absorb losses
- 18-04-2025 Capital increase of €500,000 · to €1,604,337.01 · 3,731,365 new shares · in kind
Show 30 older capital entries
- 18-04-2025 Converted to unavailable equity · €2,723,749
- 18-04-2025 Capital increase of €15 · to €1,604,352.01 · 6,053,627 new shares, 26.9% of the 22,463,989 shares after the increase · in cash
- 26-06-2023 Capital reduction of €22,330,494.74 · to €8,128,884.71 · to absorb losses
- 26-06-2023 Capital increase of €6,659,305.56 · to €14,788,190.27 · 1,640,202 new shares · in kind
- 26-06-2023 Capital increase of €131,354.17 · 32,353 new shares · in kind
- 26-06-2023 Capital increase of €226,812.50 · 55,864 new shares · in kind
- 26-06-2023 Capital increase of €99,512.83 · 24,509 new shares · in kind
- 26-06-2023 Capital increase of €30,241.67 · 7,448 new shares · in kind
- 26-06-2023 Capital increase of €52,541.67 · 12,941 new shares · in kind
- 26-06-2023 Capital increase of €20,161.11 · 4,965 new shares · in kind
- 26-06-2023 Capital increase of €187,830.77 · 46,262 new shares · in kind
- 26-06-2023 Capital increase of €268,074.70 · 66,028 new shares · in kind
- 26-06-2023 Capital increase of €6,659,305.56 · to €14,788,190.27 · 1,640,202 new shares · in kind
- 26-06-2023 Capital increase of €25 · to €14,788,215.27 · “conversion des Warrants Anti-Dilutifs”
- 09-08-2021 Capital increase of €500,000 · 80,000 new shares at €6.25 per share · in cash
- 18-01-2021 Capital increase of €8,488,910 · to €29,665,379.45 · 1,358,222 new shares at €6.25 per share · in kind
- 18-01-2021 Capital increase of €294,000 · to €29,959,379.45 · 47,040 new shares · in cash
- 14-04-2020 Capital increase of €3,825,006.25 · 612,001 new shares · in cash
- 05-03-2020 Capital increase of €7,129,350 · to €17,351,463.20 · 1,140,696 new shares, 18.4% of the 6,199,896 shares after the increase
- 20-12-2019 Capital increase of €4,000,000 · 640,000 new shares
- 12-07-2019 Capital stated in the deed · €6,222,113.20
- 12-03-2019 Capital increase of €2,605,583.20 · to €6,222,113.20 · 398,670 new shares · in kind
- 12-03-2019 Capital increase of €2,525,000 · 404,000 new shares · in cash
- 01-06-2018 Capital reduction of €7,696,851.58 · to €1,205,397.92 · to absorb losses
- 09-03-2017 Capital increase of €43,750.60 · to €8,852,252.10 · 9,511 new shares · in kind
- 09-03-2017 Capital increase of €49,997.40 · to €8,902,249.50 · 10,869 new shares, 0.3% of the 3,616,530 shares after the increase · in cash
- 16-09-2016 Capital increase of €168,500.50 · to €1,308,500.50 · 240,715 new shares at €0.70 per share
- 16-09-2016 Capital increase of €7,500,001 · to €8,808,501.50 · 1,630,435 new shares at €4.60 per share, 45.3% of the 3,596,150 shares after the increase
- 18-01-2016 Capital increase of €500,000 · to €1,140,000 · 125,000 new shares
- 14-12-2012 Incorporation · €640,000 · 6,400 shares
The directors' other companies
1 current director with another company that went bankrupt, was dissolved or struck off2 other companies of this director went bankrupt (2019, 2025).
- Air Belgium bankruptcy on 30-04-2025Official Gazetteappointed in 2024, still in office
- ELECTRAWINDS bankruptcy on 03-01-2019Official Gazetteappointed in 2009, still in office
Source: Belgian Official Gazette (bankruptcies, judicial dissolutions, board mandates), FPS Economy (strike-offs) and the KBO register. A bankruptcy, dissolution or strike-off says nothing about the director's part in it.
Network & group
Holdings
own 2025 accountsThis companyOncoDNA2 holdings, 2 countries
2025 accounts
Europe 2 Equity Result
- ES Biosequences SLU €162,009 result -€15,938
- FR Integragen66.12% -€908,525 result -€2.7m
Source: list of holdings in its own 2025 accounts. The amounts are in that list and come from the holdings' accounts at 31-12-2025, in their own currency.
The LEI register names no parent.
Earlier ties
| PRICING PACT via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Class B director · deed of 11-02-2022 Open bankruptcy · founded in 2016 |
7 FTE (2024) |
| DOMOBIOS via INVENTURES, at OncoDNA until 2021 · Director · deed of 02-04-2020 Bankrupt |
total assets €814,216 (2021) |
| BECARV via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 02-06-2021 Open bankruptcy · founded in 2011 |
8 FTE (2026) |
| ImmunXperts via SAMBRINVEST SPIN-OFF/SPIN-OUT (at OncoDNA until 2021) and Philippus JANSSENS de VAREBEKE (at OncoDNA, last mentioned in 2016) · Director · deeds of 24-01-2017 and 14-11-2016 founded in 2014 · negative equity (2024) · accounts filed late |
27 FTE (2024) |
| Indigo Diabetes via An Herremans, no longer at Indigo Diabetes · Director · deed of 28-07-2020 founded in 2016 · negative equity (2025) |
11 FTE (2025) |
| WE INVEST REAL ESTATE via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 07-06-2021 founded in 2014 · negative equity (2025) |
23 FTE (2025) |
Show 82 more earlier ties
| TRIGRR via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 31-12-2021 founded in 2021 · negative equity (2025) |
total assets €1.0m (2025) |
| Belgian Presidents Organization via François BLONDEL, no longer at Belgian Presidents Organization · Director · deed of 17-03-2020 founded in 2004 · accounts filed late |
total assets €237,985 (2025) |
| BizMotica Belgium via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 23-07-2020 founded in 2014 · negative equity (2025) |
total assets €230,853 (2025) |
| BNP Paribas Fortis via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 24-01-2014 founded in 1934 · group BNP PARIBAS |
total assets €282.82bn (2025) |
| GlaxoSmithKline Biologicals via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 08-12-2011 founded in 1990 |
8,371 FTE (2025) |
| GROUPE BRUXELLES LAMBERT via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 03-06-2013 founded in 1902 |
total assets €13.29bn (2025) |
| DELEN PRIVATE BANK via John-Eric BERTRAND, at OncoDNA until 2021 · (niet uitvoerend) b bestuurder · deed of 18-03-2025 founded in 1994 · group ACKERMANS & VAN HAAREN |
total assets €3.48bn (2025) |
| DREDGING, ENVIRONMENTAL & MARINE ENGINEERING via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 14-07-2020 founded in 1930 · group ACKERMANS & VAN HAAREN |
turnover €21.7m (2025) |
| COMPAGNIE DU BOIS SAUVAGE via François BLONDEL, no longer at COMPAGNIE DU BOIS SAUVAGE · Director · deed of 04-06-2012 founded in 1957 |
total assets €748.6m (2025) |
| BESIX Group via Jean STEPHENNE, at OncoDNA until 2021 · Permanent representative · deed of 06-01-2006 founded in 1909 |
turnover €9.3m (2025) |
| Manuchar via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 08-06-2020 founded in 1970 · group MANUCHAR GROUP |
207 FTE (2025) |
| Société Financière des Sucres via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 12-11-2025 founded in 1929 |
turnover €16.3m (2023) |
| FONDS DE LA RECHERCHE SCIENTIFIQUE-FNRS via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 25-10-2013 founded in 2006 |
2,181 FTE (2025) |
| SIPEF via John-Eric BERTRAND, at OncoDNA until 2021 · Non-executive director · deed of 29-07-2026 founded in 1919 |
turnover €288.6m (2025) |
| Société de Développement et de Participation du Bassin de Charleroi via Jean-Pol DETIFFE, at OncoDNA until 2023 · Director · deed of 20-12-2023 founded in 1985 |
turnover €3.7m (2025) |
| FONDATION CONTRE LE CANCER via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 05-12-2018 founded in 2005 |
87 FTE (2025) |
| BPC Group via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 02-07-2015 founded in 1983 · group ACKERMANS & VAN HAAREN |
301 FTE (2025) |
| Mediahuis Partners via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 24-06-2026 founded in 1976 · group Capstone Partners |
total assets €180.3m (2025) |
| Clinique Notre-Dame de Grâce via Jean-Pol DETIFFE, at OncoDNA until 2023 · Director · deed of 13-07-2021 founded in 1921 |
890 FTE (2025) |
| 6K venture capital via Jean-Pol DETIFFE, at OncoDNA until 2023 · Director · deed of 08-02-2024 founded in 2009 · group Carbon Group |
total assets €130.1m (2025) |
| Whitestone Group via François BLONDEL, no longer at Whitestone Group · Director founded in 1999 · group WHITESTONE PARTNERS, EN ABREGE : WP |
total assets €76.8m (2025) |
| ASEPTIC TECHNOLOGIES via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 06-08-2010 founded in 2002 |
61 FTE (2025) |
| Fondation Saint - Luc via Jean STEPHENNE, at OncoDNA until 2021 · Class B director · deed of 06-05-2013 founded in 2009 |
5.5 FTE (2025) |
| SAMBRELEASE via Jean-Pol DETIFFE, at OncoDNA until 2023 · Director · deed of 08-02-2024 founded in 1987 · group Carbon Group |
turnover €719,362 (2025) |
| FONDS DE CAPITAL A RISQUE 2020 via Jean-Pol DETIFFE, at OncoDNA until 2023 · Director · deed of 28-02-2024 founded in 2016 · group Carbon Group |
total assets €41.6m (2025) |
| STEEL ESTATE via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 14-04-2023 founded in 2018 |
total assets €31.9m (2025) |
| Dematic via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 16-07-2010 founded in 1947 |
144 FTE (2025) |
| n-Side via Charles-André Brouwers, no longer at n-Side · Director · deed of 09-05-2025 founded in 2000 |
161 FTE (2025) |
| Virvolti via Jean-Pol DETIFFE, at OncoDNA until 2023 · Director · deed of 13-07-2021 founded in 2007 |
30 FTE (2025) |
| BePharBel Manufacturing via SAMBRINVEST SPIN-OFF/SPIN-OUT (at OncoDNA until 2021) and Jean STEPHENNE (at OncoDNA until 2021) · Director · deeds of 11-10-2024 and 17-10-2012 founded in 2012 |
100 FTE (2025) |
| ALURAL BELGIUM via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 05-02-2010 founded in 1982 · group REYNAERS ALUMINIUM |
137 FTE (2025) |
| Uniteq via AMNASSEN, at OncoDNA, last mentioned in 2016 · Class B director · deed of 19-09-2012 founded in 2009 · group STRACO PE |
7 FTE (2025) |
| DREAMWALL via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Class C director · deed of 26-10-2026 founded in 2007 |
86 FTE (2025) |
| SOPARTEC via François BLONDEL, no longer at SOPARTEC · deed of 28-12-2022 founded in 1942 |
4.8 FTE (2025) |
| SPARKOH! via François BLONDEL, no longer at SPARKOH! · Director · deed of 20-11-2006 founded in 1997 |
42 FTE (2025) |
| CinemaNext via Pierre Flamant, at OncoDNA, last mentioned in 2018 · Director · deed of 04-11-2014 founded in 2004 |
29 FTE (2025) |
| NANOCYL via Jean STEPHENNE (at OncoDNA until 2021) and Innosté (at OncoDNA until 2023) · deeds of 07-07-2021 and 22-06-2015 founded in 2002 |
47 FTE (2026) |
| Advanced Fire Technologies via Jean-Michel Verhaegen, at OncoDNA, last mentioned in 2016 · Director · deed of 10-06-2011 founded in 1993 |
turnover €1.3m (2025) |
| ELYSIA via INVENTURES, at OncoDNA until 2021 · Director · deed of 07-06-2021 founded in 2014 |
25 FTE (2025) |
| Advanced Engineering Center via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 31-12-2021 founded in 2019 · group Carbon Group |
6.5 FTE (2025) |
| CLICTELIA via INVENTURES, at OncoDNA until 2021 · Director · deed of 13-09-2022 founded in 2009 |
27 FTE (2025) |
| THEODORUS IV via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 11-04-2025 founded in 2018 |
total assets €11.2m (2025) |
| TERRE-EN-VUE via Pierre Flamant, at OncoDNA, last mentioned in 2018 · Director · deed of 09-07-2025 founded in 2012 |
total assets €10.5m (2025) |
| CENTRE DE RESSOURCES TECHNOLOGIQUES EN CHIMIE via François BLONDEL, no longer at CENTRE DE RESSOURCES TECHNOLOGIQUES EN CHIMIE · Director founded in 1999 |
31 FTE (2025) |
| Catalent Gosselies PS via AMNASSEN (at OncoDNA, last mentioned in 2016), SAMBRINVEST SPIN-OFF/SPIN-OUT (at OncoDNA until 2021) and Philippus JANSSENS de VAREBEKE (at OncoDNA, last mentioned in 2016) · Director · deed of 07-05-2015 founded in 2001 |
33 FTE (2025) |
| BAARBEEK IMMO via An Herremans, no longer at BAARBEEK IMMO · Director · deed of 23-06-2021 founded in 2016 · group ACKERMANS & VAN HAAREN |
total assets €7.1m (2025) |
| BIO-SOURCING via Philippus JANSSENS de VAREBEKE, at OncoDNA, last mentioned in 2016 · Director · deed of 12-07-2017 founded in 2014 |
17 FTE (2025) |
| Alfa Park via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 05-04-2013 founded in 2011 · group EFFIA Belgium |
24 FTE (2025) |
| Shippr via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 25-10-2019 founded in 2017 |
7 FTE (2025) |
| CIKISI via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 01-07-2021 founded in 2016 |
6.2 FTE (2025) |
| CETIM Student RE via AMNASSEN, at OncoDNA, last mentioned in 2016 · Class B director · deed of 28-10-2021 founded in 2021 |
total assets €3.6m (2025) |
| LetsBuild Holding via INVENTURES, at OncoDNA until 2021 · Director · deed of 18-10-2022 founded in 2016 |
total assets €3.5m (2025) |
| DIGITAL ATTRAXION via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 15-06-2022 founded in 2016 |
total assets €3.2m (2025) |
| KABANDY via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 15-04-2022 founded in 2016 |
4.3 FTE (2025) |
| SHYFTER via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 08-04-2021 founded in 2019 |
18 FTE (2025) |
| BigCaptain via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director (not named in the articles) · deed of 08-01-2021 founded in 2014 |
total assets €1.3m (2025) |
| LYS MEDICAL via Jean STEPHENNE, at OncoDNA until 2021 · Director and chair of the board · deed of 04-11-2019 founded in 2018 |
total assets €1.3m (2025) |
| Pré Seed Fund via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Managing director · deed of 30-06-2023 founded in 2018 |
total assets €1.0m (2025) |
| Terre-en-vue via Pierre Flamant, at OncoDNA, last mentioned in 2018 · Director · deed of 12-10-2026 founded in 2011 |
9.7 FTE (2025) |
| HOMEDESK via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 04-07-2023 founded in 2018 |
total assets €864,812 (2025) |
| Coopérative du Grand Enclos via Pierre Flamant, at OncoDNA, last mentioned in 2018 · Director · deed of 13-05-2024 founded in 2020 |
total assets €695,990 (2025) |
| Brussels South Charleroi BioPark Dev via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 18-04-2023 founded in 2003 |
3.8 FTE (2025) |
| ARDEAM via Pierre Flamant, at OncoDNA, last mentioned in 2018 · Sole director · deed of 16-06-2023 founded in 2017 |
total assets €529,655 (2025) |
| Boost Engineering Pre-Seed Fund via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 11-06-2020 founded in 2020 |
total assets €502,902 (2025) |
| Solar 4 Success via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director (not named in the articles) · deed of 27-01-2022 founded in 2022 |
total assets €336,950 (2025) |
| Startup Vie via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Administrateur non statutaire de classe b · deed of 08-10-2020 founded in 2019 |
total assets €242,939 (2025) |
| ARETHE via Pierre LEFESVRE, at OncoDNA until 2014 · Director (not named in the articles) · deed of 14-09-2022 founded in 2022 |
total assets €124,920 (2025) |
| AMONIS via François BLONDEL, no longer at AMONIS · Independent director · deed of 13-10-2015 |
founded in 1967 |
| BANK J.VAN BREDA & C° via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 08-07-2026 group ACKERMANS & VAN HAAREN |
founded in 1930 |
| Belgian Finance Center via John-Eric BERTRAND, at OncoDNA until 2021 · Director · deed of 26-10-2023 |
founded in 2012 |
| CapriGen Animal Health via Philippus JANSSENS de VAREBEKE, at OncoDNA, last mentioned in 2016 · Director · deed of 24-11-2025 |
founded in 2025 |
| FONDS FEDERAL DE LA RECHERCHE SCIENTIFIQUE via Jean STEPHENNE, at OncoDNA until 2021 · Director · deed of 17-02-2015 |
founded in 1928 |
| Helia partners via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director (not named in the articles) · deed of 23-10-2025 |
founded in 2025 |
| ImpactVie via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 17-09-2024 |
founded in 2024 |
| NOVAFORM PHARMA via SAMBRINVEST SPIN-OFF/SPIN-OUT (at OncoDNA until 2021) and Jean STEPHENNE (at OncoDNA until 2021) · Director · deed of 15-07-2026 |
founded in 2026 |
| XA5 Partners via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director (not named in the articles) · deed of 08-08-2025 |
founded in 2025 |
| THEODORUS III via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 02-12-2019 No longer active · founded in 2013 |
total assets €909,083 (2024) |
| POSAIA via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director (not named in the articles) · deed of 12-03-2020 No longer active |
total assets €890,177 (2021) |
| SMARTBEAM via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director and permanent representative · deed of 30-05-2022 No longer active |
total assets €542,755 (2024) |
| COMPAGNIE DU BOIS SAUVAGE SERVICES via François BLONDEL, no longer at COMPAGNIE DU BOIS SAUVAGE SERVICES · Permanent representative · deed of 27-03-2013 No longer active |
turnover €84,929 (2022) |
| J.MICHEL VERHAEGEN via Jean-Michel Verhaegen, at OncoDNA, last mentioned in 2016 · Permanent representative · deed of 29-10-2014 No longer active |
total assets €134,953 (2023) |
| Advanced Engineering Accelerator via SAMBRINVEST SPIN-OFF/SPIN-OUT, at OncoDNA until 2021 · Director · deed of 22-06-2022 No longer active · group Carbon Group |
total assets €43,724 (2024) |
Holdings and subsidiaries
2 holdingsHoldings 2
Share, source and own figures per holding (2)
Source for every holding own accounts 2025
- Biosequences SLUESsubsidiaryEquity €162,009Result -€15,938100%
- IntegragenFRsubsidiaryEquity -€908,525Result -€2.7m66.12%
Board mandates elsewhere
1 board mandateBoard mandates of OncoDNAOncoDNA sits on their board1
Connections & network
4 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
COMPAGNIE D'ENTREPRISES CFE
via An Herremans · Director · deed of 07-07-2026
Founded in 1880 · 54 FTE (2025) · group ACKERMANS & VAN HAAREN
→
AGIDENS INTERNATIONAL
via An Herremans · Director · deed of 12-06-2026
Founded in 1999 · 34 FTE (2025) · group ACKERMANS & VAN HAAREN
→
INNODE
via François BLONDEL · Permanent representative · deed of 10-12-2024
Founded in 1999 · total assets €6.0m (2025)
→
→
Timeline
Timeline
52 events since 2012Board
Capital
Filings
Financial
Establishments
Address
Other
20122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
5 directors reappointedAn Herremans, Geldhof Enterprises, François Blondel, Charles-André Brouwers and Société Fédérale de Participations et d'Investissement · General meeting of 17-06-20267 points ▸
- General meeting, 17-06-2026
- Director reappointment, An Herremans
- Director reappointment, Geldhof Enterprises
- Director reappointment, François Blondel
- Director reappointment, Charles-André Brouwers
- Power of attorney, Charles-André Brouwers
- Director reappointment, Société Fédérale de Participations et d'Investissement
Annual accounts 2025 filed NBBfull format · 17 days before the deadline
Reappointment: Deloitte Réviseurs d'Entreprises (statutory auditor)General meeting of 18-07-20252 points ▸
- General meeting, 18-07-2025
- Auditor reappointment, Deloitte Réviseurs d'Entreprises (statutory auditor)
Capital increase · Amendment of the articlesCapital from €1,604,352.01 to €2,672,435.77, 1,235,636 new shares · Capital from €2,672,435.77 to €172,435.77 · Capital from €172,435.77 to €172,444.77, 171,000 new shares · General meeting of 19-05-20265 points ▸
- General meeting, 19-05-2026
- Capital increase, €1,068,083.76
- Capital decrease, €2,500,000
- Capital increase, €9
- Capital, €172,444.77, 23,870,625 shares, mentioned twice in the deed
- The deed holds 15 more points.
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0501631837
Annual accounts 2024 filed PDFfull format · 1 day before the deadline
Capital increase · Amendment of the articlesCapital from €14,788,215.27 to €1,104,337.01 · Capital from €1,104,337.01 to €1,604,337.01, 3,731,365 new shares · Capital from €1,604,337.01 to €1,604,352.01, 6,053,627 new shares · General meeting of 28-03-202510 points ▸
- General meeting, 28-03-2025
- Auditor report, 13-03-2025
- Capital decrease, €13,683,878.26, mentioned twice in the deed
- Share transfer, 214,713 shares, mentioned twice in the deed
- Capital increase, €500,000, mentioned twice in the deed
- Capital increase, €15, mentioned twice in the deed
- Capital, €1,604,352.01
- Power of attorney, Hadrien Chef
- Power of attorney, Violette Keppenne
- Power of attorney, Mathilde Drion
- The deed holds 22 more points.
2024
- General meeting, 28-07-2024
- Director resignation, William E. Rhodes, III
Annual accounts 2023 filed PDFfull format · 8 days before the deadline
New financial directorFinadec SRL appointed, Bernard Courtieu resigned · Permanent representatives: Virginie De Coster, Jean-Pol Detiffe, François Degrave and Manuelle Puissant · Board meeting of 04-04-202412 points ▸
- Board meeting, 04-04-2024
- Director resignation, Bernard Courtieu (director general)
- Power of attorney, Bernard Courtieu
- Director appointment, Finadec SRL (financial director)
- Permanent representative, Virginie De Coster
- Power of attorney, Finadec SRL
- Permanent representative, Jean-Pol Detiffe
- Permanent representative, François Degrave
- Permanent representative, Manuelle Puissant
- Power of attorney, Finadec SRL (CFO)
- Power of attorney, Bilal Yahya (business controller)
- Power of attorney, Charles-André Brouwers
- The deed holds 9 more points.
2023
Weakest financial year net -€10.4m The net result drops to -€10.4m, the lowest from 2013 to 2025. It recovers the following year.
Annual accounts 2022 filed PDFfull format · 26 days before the deadline
Capital increaseCapital from €30,459,379.45 to €8,128,884.71 · Capital from €8,128,884.71 to €14,788,190.27, 1,640,202 new shares · Capital from €14,788,190.27 to €14,788,215.27 · General meeting of 20-06-202370 points ▸
- General meeting, 20-06-2023, mentioned twice in the deed
- Jean-Pol DETIFFE holds 278,538 shares
- Jean-Pol DETIFFE holds 6,646 shares
- Jean-Pol DETIFFE holds 384,285 shares
- INVEST4ONCODNA holds 426,036 shares
- INVEST4ONCODNA holds 35,903 shares
- Vinsovier SA holds 302,140 shares
- Vinsovier SA holds 12,153 shares
- Jean-Marie HENROTIN holds 97,483 shares
- BIO.be SA holds 560,801 shares
- BIO.be SA holds 32,428 shares
- Sambrinvest Spin-Off /Spin-Out SA holds 512,993 shares
- Sambrinvest Spin-Off /Spin-Out SA holds 277,251 shares
- Michael HERMAN holds 3,504 shares
- Gregori GHITTI holds 3,504 shares
- Jean-François LAES holds 6,469 shares
- INVENTURES holds 217,391 shares
- INVENTURES holds 40,277 shares
- AvH Growth Capital SA holds 597,826 shares
- AvH Growth Capital SA holds 282,521 shares
- Wallonie Entreprendre SA holds 326,087 shares
- Wallonie Entreprendre SA holds 390,455 shares
- Banque CPH SCRL holds 271,739 shares
- Banque CPH SCRL holds 364,488 shares
- Adriana TERRADEZ LAVERGNE holds 1,150 shares
- Pierre FLAMANT holds 10,869 shares
- Société Fédérale de Participations et d’Investissement – Federale Participatie - en Investeringsmaatschappij holds 1,291,800 shares
- Vesalius Biocapital III S.C.A. SICAR holds 803,933 shares
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK holds 803,733 shares
- Verve Investment Syndicates GmbH holds 147,041 shares
- Future Capital AG holds 99,200 shares
- David WICKI-BIRCHLER holds 92,800 shares
- Spreds Finance SA is a shareholder
- Capital decrease, €22,330,494.74, mentioned twice in the deed
- Capital increase, €6,659,305.56, mentioned 3 times in the deed
- Capital increase, €25, mentioned twice in the deed
- Financial instrument, 15, 1
- Power of attorney, Philippe DUPUIS
- Capital, €8,128,884.71, 8,297,159 shares
- Capital increase, €131,354.17
- Capital increase, €226,812.50
- Capital increase, €99,512.83
- Capital increase, €30,241.67
- Capital increase, €52,541.67
- Capital increase, €20,161.11
- Capital increase, €187,830.77
- Capital increase, €268,074.70
- Capital, €14,788,190.27
- Jean-Pol DETIFFE is a shareholder
- INVEST4ONCODNA is a shareholder
- Vinsovier SA is a shareholder
- BIO.be SA is a shareholder
- Sambrinvest Spin-Off /Spin-Out SA is a shareholder
- INVENTURES is a shareholder
- AvH Growth Capital SA is a shareholder
- Wallonie Entreprendre SA is a shareholder
- Banque CPH SCRL is a shareholder
- Société Fédérale de Participations et d’Investissement – Federale Participatie - en Investeringsmaatschappij is a shareholder
- Vesalius Biocapital III S.C.A. SICAR is a shareholder
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK is a shareholder
- Verve Investment Syndicates GmbH is a shareholder
- Future Capital AG is a shareholder
- David WICKI-BIRCHLER is a shareholder
- Capital, €14,788,215.27
- Auditor report, 18-06-2023
- Capital increase, €corresponding to exercise
- Financial instrument, 1, subscription, mentioned 15 times in the deed
- Capital, €14,788,215.27, 12,678,997 shares
- Share cancellation, 01-09-2016
- Jean-Marie HENROTIN is a shareholder
- The deed holds 51 more points.
6 directors appointed, 10 resignationsResignations: Alain Declercq, Swisscanto (CH) Private Equity Switzerland Growth I KmGK, Innoste, Jean-Pol Detiffe, Société Fédérale de Participations et d'Investissement, An Herremans and 4 others · Permanent representatives: Robert Schier, Jean Stéphenne, François Fontaine and Guy Geldhof · Appointments: Société Fédérale de Participations et d'Investissement, An Herremans, Geldhof Enterprises, François Blondel, William R. "Bill" Rhodes and Charles-André Brouwers · General meeting of 17-05-202321 points ▸
- General meeting, 17-05-2023
- Director resignation, Alain Declercq
- Director resignation, Swisscanto (CH) Private Equity Switzerland Growth I KmGK
- Permanent representative, Robert Schier
- Director resignation, Innoste
- Permanent representative, Jean Stéphenne
- Director resignation, Jean-Pol Detiffe
- Director resignation, Société Fédérale de Participations et d'Investissement
- Director resignation, An Herremans
- Director resignation, Geldhof Enterprises
- Director resignation, François Blondel
- Director resignation, William R. "Bill" Rhodes
- Director resignation, Charles-André Brouwers
- Permanent representative, François Fontaine
- Permanent representative, Guy Geldhof
- Director appointment, Société Fédérale de Participations et d'Investissement
- Director appointment, An Herremans
- Director appointment, Geldhof Enterprises
- Director appointment, François Blondel
- Director appointment, William R. "Bill" Rhodes
- Director appointment, Charles-André Brouwers
- The deed holds 2 more points.
2022
2 directors appointed, 1 resignationAppointments: François Degrave (member of the executive committee) and Koenraad Eycken (member of the executive committee) · Resignation: Synneo SRL (member of the executive committee) · Registered office clause: Rue Louis Breguet 1, 6041 Charleroi (Gosselies), Belgique · Board meeting of 28-04-20225 points ▸
- Board meeting, 28-04-2022
- Director appointment, François Degrave (member of the executive committee)
- Director resignation, Synneo SRL (member of the executive committee)
- Director appointment, Koenraad Eycken (member of the executive committee)
- Registered office clause, Rue Louis Breguet 1, 6041 Charleroi (Gosselies), Belgique
10 directors reappointed, 1 statutory auditor reappointedJean-Pol Detiffe, François Blondel, Alain Declercq, An Herremans, Charles-André Brouwers, William R. "Bill" Rhodes and 5 others · Permanent representatives: Guy Geldhof, Robert Schier, Jean Stéphenne and François Fontaine · General meeting of 02-06-202216 points ▸
- General meeting, 02-06-2022
- Director reappointment, Jean-Pol Detiffe
- Director reappointment, François Blondel
- Director reappointment, Alain Declercq
- Director reappointment, An Herremans
- Director reappointment, Charles-André Brouwers
- Director reappointment, William R. "Bill" Rhodes
- Director reappointment, Geldhof Enterprises
- Permanent representative, Guy Geldhof
- Director reappointment, Swisscanto (CH) Private Equity Switzerland Growth I KmGK
- Permanent representative, Robert Schier
- Director reappointment, Innoste
- Permanent representative, Jean Stéphenne
- Director reappointment, Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij
- Permanent representative, François Fontaine
- Auditor reappointment, Deloitte Réviseurs d'Entreprises SRL (statutory auditor)
Annual accounts 2021 filed PDFfull format · 39 days before the deadline
2021
Capital increase of €500,00080,000 new shares · Resignations: INVENTURES, BIO.BE and John-Eric BERTRAND · Permanent representatives: Olivier DE DUVE and Jean-François Ghidetti · General meeting of 02-07-202144 points ▸
- General meeting, 02-07-2021
- Jean-Pol DETIFFE is a shareholder, mentioned twice in the deed
- INVEST4ONCODNA is a shareholder, mentioned twice in the deed
- VINSOVIER is a shareholder, mentioned twice in the deed
- Jean-Marie HENROTIN is a shareholder, mentioned twice in the deed
- BIO.BE is a shareholder, mentioned twice in the deed
- SAMBRINVEST SPIN-OFF/SPIN-OUT is a shareholder
- Michael HERMAN is a shareholder, mentioned twice in the deed
- Gregori GHITTI is a shareholder, mentioned twice in the deed
- Jean-François LAES is a shareholder, mentioned twice in the deed
- INVENTURES is a shareholder, mentioned twice in the deed
- AVH GROWTH CAPITAL is a shareholder, mentioned twice in the deed
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE is a shareholder
- BANQUE CPH is a shareholder
- Adriana TERRADEZ LAVERGNE is a shareholder, mentioned twice in the deed
- Pierre FLAMANT is a shareholder, mentioned twice in the deed
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij is a shareholder
- Vesalius Biocapital III S.C.A SICAR is a shareholder
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK is a shareholder
- Verve Investment Syndicates GmbH is a shareholder, mentioned twice in the deed
- Future Capital AG holds 99,200 shares
- Power of attorney, Freitas Da Silva Catia
- David WICKI-BIRCHLER holds 92,800 shares
- Power of attorney, Pierre FLAMANT
- Capital increase, €500,000, mentioned twice in the deed
- Auditor report, 29-06-2021
- Capital, €30,459,379.45
- Sambrinvest is a shareholder
- SRIW is a shareholder
- CPH is a shareholder
- Société Fédérale de Participation et d'Investissement is a shareholder
- Vesalius is a shareholder
- Swisscanto is a shareholder
- Future Capital AG is a shareholder
- David WICKI-BIRCHLER is a shareholder
- Amendment of the articles, article 4
- Director resignation, INVENTURES
- Director resignation, BIO.BE
- Director resignation, John-Eric BERTRAND
- Permanent representative, Olivier DE DUVE
- Permanent representative, Jean-François Ghidetti
- Director appointment, Charles-André BROUWERS (independent director)
- Director appointment, William R. "Bill" RHODES (independent director)
- Director appointment, An HERREMANS
- The deed holds 17 more points.
New director generalBernard Courtieu appointed, Ignis Consulting SARL resigned · Board meeting of 12-04-20216 points ▸
- Board meeting, 12-04-2021
- Director resignation, Ignis Consulting SARL (director general)
- Director appointment, Bernard Courtieu (director general)
- Power of attorney, Ardeam SRL
- Power of attorney, Business Controller, mentioned 3 times in the deed
- Power of attorney, CEO
- The deed holds 10 more points.
Annual accounts 2020 filed PDFfull format · 40 days before the deadline
3 directors appointed, 2 resignationsCapital from €21,176,469.45 to €29,665,379.45 · Capital from €29,665,379.45 to €29,959,379.45, 47,040 new shares · Contributions: Jean-Pol DETIFFE (€16,542, 2,646 shares); VINSOVIER (€25,615, 4,098 shares); BIO.BE (€102,458, 16,393 shares); and 10 others · General meeting of 23-12-202070 points ▸
- General meeting, 23-12-2020
- Jean-Pol DETIFFE is a shareholder, mentioned 3 times in the deed
- Power of attorney, LONGTON Charles, mentioned 17 times in the deed
- INVEST4ONCODNA holds 438,119 shares
- VINSOVIER holds 310,195 shares
- BIO.BE holds 576,836 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT holds 790,244 shares
- Michael HERMAN holds 3,504 shares
- Gregori GHITTI holds 3,504 shares
- Jean-François LAES holds 6,469 shares
- INVENTURES holds 257,668 shares
- AVH GROWTH CAPITAL holds 798,381 shares
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE holds 470,642 shares
- BANQUE CPH holds 472,294 shares
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij holds 720,000 shares
- Vesalius Biocapital III S.C.A. SICAR holds 640,000 shares
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK holds 640,000 shares
- Verve Investment Syndicates GmbH holds 132,001 shares
- Future Capital AG holds 80,000 shares
- Power of attorney, FREITAS DA SILVA Catia
- David WICKI-BIRCHLER holds 80,000 shares
- Capital increase, €8,488,910, mentioned twice in the deed
- Capital increase, €294,000, mentioned twice in the deed
- Financial instrument, 3, 15, mentioned 15 times in the deed
- Financial instrument, 4.2, 15
- Director appointment, Innoste SA, mentioned twice in the deed
- Auditor report, Deloitte Réviseurs d'Entreprises SCRL
- Capital contribution, €16,542
- Capital contribution, €25,615
- Capital contribution, €102,458
- Capital contribution, €512,292
- Capital contribution, €1,024,583, mentioned twice in the deed
- Capital contribution, €1,536,875
- Capital contribution, €3,073,750
- Capital contribution, €1,023,333
- INVEST4ONCODNA is a shareholder
- VINSOVIER is a shareholder
- Jean-Marie Henrotin is a shareholder
- BIO.BE is a shareholder
- SAMBRINVEST SPIN-OFF/SPIN-OUT is a shareholder
- Michael HERMAN is a shareholder
- Gregori GHITTI is a shareholder
- INVENTURES is a shareholder
- Jean-François LAES is a shareholder
- AVH GROWTH CAPITAL is a shareholder
- Adriana Terradez Lavergne is a shareholder
- Pierre Flamant is a shareholder, mentioned twice in the deed
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij is a shareholder
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK is a shareholder
- Verve Investment Syndicates GmbH is a shareholder, mentioned twice in the deed
- Future Capital AG is a shareholder, mentioned twice in the deed
- David WICKI-BIRCHLER is a shareholder, mentioned twice in the deed
- Capital, €29,665,379.45
- Capital contribution, €94,000
- Capital contribution, €120,000
- Capital contribution, €80,000
- Capital, €29,959,379.45
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE is a shareholder
- BANQUE CPH is a shareholder
- Vesalius Biocapital III S.C.A. SICAR is a shareholder
- Financial instrument, 1, 15, mentioned 15 times in the deed
- Auditor report, 14-12-2020
- Financial instrument, 15, 4.2
- Director resignation, Jean Stéphenne
- Permanent representative, Jean Stéphenne
- Director resignation, SAMBRINVEST SPIN-OFF/SPIN-OUT
- Director appointment, Alain Declercq (director (not named in the articles))
- Director appointment, Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (director (not named in the articles))
- Permanent representative, François Fontaine
- Capital contribution, €148,879
- The deed holds 48 more points.
2020
Equity above €10m equity €15.9m ▲252% Equity rises from €4.5m to €15.9m.
New chair of the boardInnoste SA appointed, Jean Stéphenne resigned · Permanent representative: Jean Stéphenne4 points ▸
- Director resignation, Jean Stéphenne (director and chair of the board)
- Director appointment, Innoste SA
- Permanent representative, Jean Stéphenne
- Director appointment, Innoste SA (chair of the board)
- The deed holds 1 more point.
Annual accounts 2019 filed PDFfull format · 29 days before the deadline
Capital increase of €3,825,006.25612,001 new shares · Contributions: Verve Investment Syndicates GmbH (€825,006.25, 132,001 shares); Future Capital AG (€500,000, 80,000 shares); David Wicki-Birchler (€500,000, 80,000 shares); and 1 other · Jean-Pol DETIFFE holds 282,538 shares · General meeting of 12-03-202054 points ▸
- General meeting, 12-03-2020
- Jean-Pol DETIFFE holds 282,538 shares
- Jean-Pol DETIFFE holds 384,285 shares
- INVEST4ONCODNA holds 438,119 shares
- VINSOVIER holds 310,195 shares
- Jean-Marie HENROTIN holds 89,122 shares
- BIO.BE holds 576,836 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT holds 799,244 shares
- Michael HERMAN holds 3,504 shares
- Gregori GHITTI holds 3,504 shares
- Jean-François LAES holds 6,469 shares
- INVENTURES holds 257,668 shares
- SOFINIM holds 798,381 shares
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE holds 470,642 shares
- BANQUE CPH holds 472,294 shares
- Adriana TERRADEZ LAVERGNE holds 1,150 shares
- BUSINESS INNOVATION S.L. holds 8,361 shares
- Pierre FLAMANT holds 10,869 shares
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij holds 400,000 shares
- Vesalius Biocapital III S.C.A. SICAR holds 640,000 shares
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK holds 640,000 shares
- Capital increase, €3,825,006.25, mentioned twice in the deed
- Capital contribution, €825,006.25
- Capital contribution, €500,000, mentioned twice in the deed
- Capital contribution, €2,000,000
- Power of attorney, Jonathan Flameng
- Jean-Pol DETIFFE is a shareholder
- INVEST4ONCODNA is a shareholder
- VINSOVIER is a shareholder
- Jean-Marie HENROTIN is a shareholder
- BIO.BE is a shareholder
- Michael HERMAN is a shareholder
- Gregori GHITTI is a shareholder
- Jean-François LAES is a shareholder
- INVENTURES is a shareholder
- Adriana TERRADEZ LAVERGNE is a shareholder
- BUSINESS INNOVATION S.L. is a shareholder
- Pierre FLAMANT is a shareholder
- Capital, €21,176,469.45, mentioned twice in the deed
- Vesalius Biocapital III S.C.A. SICAR is a shareholder
- Swisscanto (CH) Private Equity Switzerland Growth I KmGK is a shareholder
- Verve Investment Syndicates GmbH is a shareholder
- Future Capital AG is a shareholder
- David Wicki-Birchler is a shareholder
- Auditor report, 10-03-2020, mentioned twice in the deed
- Financial instrument, 15, 1
- Financial instrument, 1, subscription, mentioned 15 times in the deed
- Power of attorney, Philippe DUPUIS
- SAMBRINVEST SPIN-OFF/SPIN-OUT is a shareholder
- SOFINIM is a shareholder
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE is a shareholder
- BANQUE CPH is a shareholder
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij is a shareholder
- Financial instrument, 07-02-2020
- The deed holds 35 more points.
Capital increase of €7,129,3501,140,696 new shares · Appointment: Swisscanto (CH) Private Equity Switzerland Growth I KmGK (director) · Permanent representative: Robert Schier · General meeting of 07-02-202050 points ▸
- General meeting, 07-02-2020
- Jean-Pol DETIFFE holds 282,538 shares
- INVEST4ONCODNA holds 438,119 shares
- VINSOVIER holds 310,195 shares
- Jean-Marie HENROTIN holds 89,122 shares
- BIO.BE holds 576,836 shares
- SAMBRINVEST SPIN-OFF/SPIN-OUT holds 593,548 shares
- Michael HERMAN holds 3,504 shares
- Gregori GHITTI holds 3,504 shares
- Jean-François LAES holds 6,469 shares
- INVENTURES holds 257,668 shares
- SOFINIM holds 678,381 shares
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE holds 406,642 shares
- BANQUE CPH holds 352,294 shares
- Adriana TERRADEZ LAVERGNE holds 1,150 shares
- BUSINESS INNOVATION holds 8,361 shares
- Pierre FLAMANT holds 10,869 shares
- Société Fédérale de Participations et d'Investissement - Federale Participatie - en Investeringsmaatschappij holds 400,000 shares
- Vesalius Biocapital III S.C.A. SICAR holds 640,000 shares
- Power of attorney, Pierre FLAMANT, mentioned 16 times in the deed
- 5,059,200 shares
- Capital increase, €7,129,350, mentioned twice in the deed
- Amendment of the articles, article 4, mentioned twice in the deed
- Amendment of the articles, article 11, mentioned twice in the deed
- Amendment of the articles, article 12, mentioned twice in the deed
- Share issue, 640,000, 1,140,696
- Jean-Pol DETIFFE is a shareholder
- INVEST4ONCODNA is a shareholder
- VINSOVIER is a shareholder
- Jean-Marie HENROTIN is a shareholder
- BIO.BE is a shareholder
- SAMBRINVESTSPIN-OFF/SPIN-OUT is a shareholder
- Michael HERMAN is a shareholder
- Gregori GHITTI is a shareholder
- Jean-François LAES is a shareholder
- INVENTURES is a shareholder
- SOFINIM is a shareholder
- SOCIETEREGIONALED'INVESTISSEMENTDEWALLONIE is a shareholder
- BANQUECPH is a shareholder
- Adriana TERRADEZ LAVERGNE is a shareholder
- BUSINESSINNOVATIONS.L. is a shareholder
- Pierre FLAMANT is a shareholder
- SociétéFédéraledeParticipationsetd'Investissement-FederaleParticipatie-enInvesteringsmaatschappij is a shareholder
- VesaliusBiocapitalIIIS.C.A.SICAR is a shareholder
- Swisscanto(CH)PrivateEquitySwitzerlandGrowthIKmGK is a shareholder
- Auditor report, 31-01-2020
- Financial instrument, 1, 12
- Power of attorney, Philippe DUPUIS
- Director appointment, Swisscanto (CH) Private Equity Switzerland Growth I KmGK (director (not named in the articles))
- Permanent representative, Robert Schier
- The deed holds 37 more points.
2019
Liquidity more than doubled current ratio 1.90 The current ratio rises from 0.87 to 1.90. Short-term debt falls from €3.4m to €2.6m.
Capital increase of €4,000,000640,000 new shares · Appointments: INVENTURES, BIO.BE, BLONDEL François, SAMBRINVEST SPIN-OFF/SPIN-OUT, BERTRAND John-Eric Fernand Pascal César, Jean-Pol DETIFFE and 2 others · Permanent representatives: de Duve Olivier, Jean-François GHIDETTI, STREEL Micheline Antoinette Georges Marie Joseph and Guy GELDHOF · General meeting of 25-11-201948 points ▸
- General meeting, 25-11-2019
- Jean-Pol DETIFFE holds 282,538 shares, mentioned twice in the deed
- Jean-Pol DETIFFE holds 384,285 shares
- Power of attorney, Pierre FLAMANT, mentioned 16 times in the deed
- INVEST4ONCODNA holds 438,119 shares, mentioned twice in the deed
- VINSOVIER holds 310,195 shares, mentioned twice in the deed
- Jean-Marie HENROTIN holds 89,122 shares, mentioned twice in the deed
- BIO.BE holds 576,836 shares, mentioned twice in the deed
- SAMBRINVEST SPIN-OFF/SPIN-OUT holds 593,548 shares
- Michael HERMAN holds 3,504 shares, mentioned twice in the deed
- Gregori GHITTI holds 3,504 shares, mentioned twice in the deed
- Jean-François LAES holds 6,469 shares, mentioned twice in the deed
- INVENTURES holds 257,668 shares, mentioned twice in the deed
- SOFINIM holds 678,381 shares, mentioned twice in the deed
- SOCIETE REGIONALE D'INVESTISSEMENT DE WALLONIE holds 406,642 shares
- BANQUE CPH holds 352,294 shares, mentioned twice in the deed
- Adriana TERRADEZ LAVERGNE holds 1,150 shares
- BUSINESS INNOVATION S.L. holds 8,361 shares, mentioned twice in the deed
- Pierre FLAMANT holds 10,869 shares, mentioned twice in the deed
- Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij holds 400,000 shares, mentioned twice in the deed
- 4,419,200 shares, mentioned twice in the deed
- Capital increase, €4,000,000, mentioned twice in the deed
- Financial instrument, 11, 1, mentioned twice in the deed
- Sambrinvest holds 593,548 shares
- SRIW holds 406,642 shares
- Adrana Terradez Lavergne holds 1,150 shares
- Vesalius Biocapital III S.C.A. SICAR holds 640,000 shares
- Auditor report, 20-11-2019
- Financial instrument, 1, 1
- Financial instrument, 2, 1
- Financial instrument, 3, 1
- Financial instrument, 4, 1
- Financial instrument, 1, subscription, mentioned 7 times in the deed
- Capital, €10,222,113.20, 5,059,200 shares
- Power of attorney, Philippe DUPUIS
- Director appointment, INVENTURES (director (not named in the articles))
- Director appointment, BIO.BE (director (not named in the articles))
- Director appointment, BLONDEL François (director (not named in the articles))
- Director appointment, SAMBRINVEST SPIN-OFF/SPIN-OUT (director (not named in the articles))
- Director appointment, BERTRAND John-Eric Fernand Pascal César (director (not named in the articles))
- Director appointment, Jean-Pol DETIFFE (director (not named in the articles))
- Director appointment, STEPHENNE Jean Raymond Ghislain (director (not named in the articles))
- Director appointment, GELDHOF ENTERPRISES (director (not named in the articles))
- Permanent representative, de Duve Olivier
- Permanent representative, Jean-François GHIDETTI
- Permanent representative, STREEL Micheline Antoinette Georges Marie Joseph
- Permanent representative, Guy GELDHOF
- Registered office clause, (6041) Charleroi (Gosselies), Avenue Louis Breguet 1
- The deed holds 42 more points.
Amendment of the articlesCapital of €6,222,113.20, 4,419,200 shares · General meeting of 15-02-20192 points ▸
- General meeting, 15-02-2019
- Capital, €6,222,113.20, 4,419,200 shares
- The deed holds 1 more point.
Reappointment: Deloitte Réviseurs d'Entreprises SCRL (statutory auditor)General meeting of 18-06-20192 points ▸
- General meeting, 18-06-2019
- Auditor reappointment, Deloitte Réviseurs d'Entreprises SCRL
Annual accounts 2018 filed PDFfull format · 26 days before the deadline
Appointment: Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij (director)Capital from 3616530 to 6222113.20, 398,670 new shares · Capital from 6222113.20 to 8747113.20, 404,000 new shares · Mandate compensation: Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij · General meeting of 15-02-20196 points ▸
- General meeting, 15-02-2019
- Capital increase, €2,605,583.20
- Capital increase, €2,525,000
- Capital, €8,747,113.20, 4,419,200 shares
- Director appointment, Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij
- Mandate compensation, Société Fédérale de Participations et d'Investissement - Federale Participatie- en Investeringsmaatschappij
- The deed holds 2 more points.
2018
5 directors appointedJean-Pol Detiffe (director general), Pierre Flamant (CFO), Jean-François Laes (cto), Grégori Ghitti (it director) and Michelle Meijer (sales director) · Mandate compensation: ONCODNA · Board meeting of 08-05-201813 points ▸
- Board meeting, 08-05-2018
- Board composition, Ignis Counsulting SARL (member of the executive committee)
- Board composition, Ardeam SPRL (member of the executive committee)
- Board composition, Jean-François Laes (member of the executive committee)
- Board composition, Grégori Ghitti (member of the executive committee)
- Board composition, Michelle Meijer (member of the executive committee)
- Mandate compensation, ONCODNA
- Power of attorney, Ardeam SPRL
- Director appointment, Jean-Pol Detiffe (director general)
- Director appointment, Pierre Flamant (CFO)
- Director appointment, Jean-François Laes
- Director appointment, Grégori Ghitti (it director)
- Director appointment, Michelle Meijer (sales director)
- The deed holds 1 more point.
Annual accounts 2017 filed PDFfull format · 40 days before the deadline
Capital decrease of €7,696,851.58Capital from 8.902.249,50 to 1.205.397,92 · Reappointment: INVENTURES (director) · General meeting of 28-05-20187 points ▸
- General meeting, 28-05-2018
- Net-asset statement, 31-03-2018
- Capital decrease, €7,696,851.58
- Capital, €1,205,397.92, 3,616,530 shares
- Power of attorney, Philippe DUPUIS
- Director reappointment, INVENTURES
- Power of attorney, ONCODNA
- The deed holds 1 more point.
2017
Annual accounts 2016 filed PDFfull format · 55 days before the deadline
Registered office moved within CharleroiNew registered office: avenue Louis Breguet 1, 6041 Charleroi · Previous registered office: 1 Avenue Louis Breguet 6041 Charleroi · Appointments: Ignis Counsulting SARL, Jean-François Laes and Pierre Flamant · Board meeting of 06-02-20179 points ▸
- Board meeting, 06-02-2017
- Director appointment, Ignis Counsulting SARL (member of the executive committee)
- Director appointment, Jean-François Laes (member of the executive committee)
- Director appointment, Pierre Flamant (member of the executive committee)
- Mandate compensation, Ignis Counsulting SARL
- Mandate compensation, Jean-François Laes
- Mandate compensation, Pierre Flamant
- Power of attorney, Pierre Flamant
- Registered-office move, avenue Louis Breguet 1, 6041 Charleroi
Registered office moved within CharleroiCapital from €8,808,501.50 to €8,852,252.10, 9,511 new shares · Capital from €8,852,252.10 to €8,902,249.50, 10,869 new shares · New registered office: Avenue Louis Breguet 1, 6041 Charleroi (Gosselies) · General meeting of 16-02-201711 points ▸
- General meeting, 16-02-2017
- Capital increase, €43,750.60
- Capital increase, €49,997.40
- Capital, €8,902,249.50, 3,616,530 shares
- Registered-office move, Avenue Louis Breguet 1, 6041 Charleroi (Gosselies)
- Board meeting, 06-02-2017
- Director appointment, INVENTURES
- Permanent representative, Olivier de DUVE
- Mandate compensation, INVENTURES
- Power of attorney, Conseil d'Administration
- Acquisition, 01-12-2016
- The deed holds 3 more points.
2016
Equity above €2m equity €2.3m ▲294% Equity rises from €572,571 to €2.3m.
Appointment: Deloitte Réviseurs d'Entreprises SC s.f.d. SCRL (statutory auditor)Mandate compensation: Deloitte Réviseurs d'Entreprises SC s.f.d. SCRL · General meeting of 16-11-20163 points ▸
- General meeting, 16-11-2016
- Auditor appointment, Deloitte Réviseurs d'Entreprises SC s.f.d. SCRL (statutory auditor)
- Mandate compensation, Deloitte Réviseurs d'Entreprises SC s.f.d. SCRL
2 directors appointed, 2 resignationsResignations: AMNASSEN SPRL (chair of the board) and Jean-Pol DETIFFE (managing director) · Appointments: Jean STEPHENNE (chair of the board) and IGNIS CONSULTING SARL (daily management delegate) · Permanent representative: Jean-Pol DETIFFE · Board meeting of 01-09-20168 points ▸
- Board meeting, 01-09-2016
- Director resignation, AMNASSEN SPRL (chair of the board)
- Director appointment, Jean STEPHENNE (chair of the board)
- Director resignation, Jean-Pol DETIFFE (managing director)
- Director appointment, IGNIS CONSULTING SARL (daily management delegate)
- Permanent representative, Jean-Pol DETIFFE
- Power of attorney, Fieldfisher (Belgium) LLP
- Power of attorney, Corpoconsult Sprl
7 directors appointedCapital from 1140000.00 to 1308500.50, 240,715 new shares · Capital from 1308500.50 to 8808501.50, 1,630,435 new shares · John-Eric BERTRAND, SPARAXIS, BIO.BE, SAMBRINVEST SPIN-OFF/SPIN-OUT, AMNASSEN, Jean STÉPHENNE and 1 other · General meeting of 01-09-201625 points ▸
- General meeting, 01-09-2016
- Capital increase, €168,500.50
- Capital increase, €7,500,001
- Share issue, 217,391, 999998.60
- Share issue, 597,826, 2749999.60
- Share issue, 326,087, 1500000.20
- Share issue, 271,739, 1249999.40
- Share issue, 21,739, 99999.40, mentioned 3 times in the deed
- Share issue, 32,609, 150001.40
- Share issue, 108,696, 500001.60
- Share issue, 10,870, 50002.00
- Capital, €8,808,501.50, 3,596,150 shares
- Director appointment, John-Eric BERTRAND
- Director appointment, SPARAXIS
- Permanent representative, Géry LEFEBVRE
- Director appointment, BIO.BE
- Permanent representative, Michel PETEIN
- Director appointment, SAMBRINVEST SPIN-OFF/SPIN-OUT
- Permanent representative, Micheline STREEL
- Director appointment, AMNASSEN
- Permanent representative, François Robert BLONDEL
- Director appointment, Jean STÉPHENNE
- Director appointment, Jean-Pol DETIFFE
- Mandate compensation, Jean-Pol DETIFFE
- Power of attorney, ONCODNA
- The deed holds 6 more points.
7 directors reappointedAMNASSEN, Philippus JANSSENS de VAREBEKE, Sambrinvest Spin-Off/Spin-Out, Jean-Pol DETIFFE, BIO.BE, Jean-Michel VERHAEGEN and 1 other · Permanent representatives: François Blondel, Micheline Streel and Michel Pétein · General meeting of 14-06-201611 points ▸
- General meeting, 14-06-2016
- Director reappointment, AMNASSEN
- Permanent representative, François Blondel
- Director reappointment, Philippus JANSSENS de VAREBEKE
- Director reappointment, Sambrinvest Spin-Off/Spin-Out
- Permanent representative, Micheline Streel
- Director reappointment, Jean-Pol DETIFFE
- Director reappointment, BIO.BE
- Permanent representative, Michel Pétein
- Director reappointment, Jean-Michel VERHAEGEN
- Director reappointment, Jean STEPHENNE
Annual accounts 2015 filed PDFfull format · 20 days before the deadline
Capital increase of €500,000Capital from €640,000 to €1,140,000, 125,000 new shares · General meeting of 15-12-20155 points ▸
- General meeting, 15-12-2015
- Capital increase, €500,000
- Accounting effect, 01-01-2016
- Capital, €1,140,000
- Share division, 250, 37,500
- The deed holds 2 more points.
2015
Equity above €500,000 equity €572,571 ▲9,311% Equity rises from €6,084 to €572,571.
Annual accounts 2014 filed PDFfull format · 38 days before the deadline
- Board meeting, 20-01-2015
- Director resignation, Pierre LEFESVRE
Share cancellationCancellation of 1,000 shares · General meeting of 25-03-20151 point ▸
- General meeting, 25-03-2015
- The deed holds 4 more points.
2014
Annual accounts 2013 filed PDFfull format · 34 days before the deadline
2013
First establishment Rue Louis Breguet 1, Charleroi
2012
IncorporationFounding capital of €640,000, 6,400 shares · Appointments: Jean-Pol DETIFFE (daily management delegate), Pierre LEFESVRE, Philippe JANSSENS de VAREBEKE, AMNASSEN (chair of the board), BIO.BE, Jean-Michel VERHAEGEN and 2 others · Permanent representatives: François BLONDEL, Michel PETEIN and Micheline STREEL · published on 14-12-201220 points ▸
- Founding capital, €640,000, 6,400 shares
- General meeting, 23-11-2012
- Director appointment, Jean-Pol DETIFFE
- Director appointment, Pierre LEFESVRE
- Director appointment, Philippe JANSSENS de VAREBEKE
- Director appointment, AMNASSEN
- Permanent representative, François BLONDEL
- Director appointment, BIO.BE
- Permanent representative, Michel PETEIN
- Director appointment, Jean-Michel VERHAEGEN
- Director appointment, SAMBRINVEST SPIN-OFF/SPIN-OUT
- Permanent representative, Micheline STREEL
- Director appointment, Jean STEPHENNE
- Mandate compensation, ONCODNA
- Board meeting, 23-11-2012
- Director appointment, AMNASSEN (chair of the board)
- Director appointment, Jean-Pol DETIFFE (daily management delegate)
- Share payment, €160,000
- First general meeting, 2014
- Board composition, 8, 4
- The deed holds 1 more point.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 29 November 2012, OncoDNA was incorporated by INVEST4ONCODNA, BIO.BE, SAMBRINVEST SPIN-OFF/SPIN-OUT and four natural persons, with a starting capital of €640,000.12 The capital was increased 12 times between 2016 and 2026, most recently to €2.7m.345 In 2017 the registered office moved to Charleroi.6 Today the board has 5 members.7 Total assets went from €7.5m in 2018 to €5.3m in 2025 and headcount from 38.1 to 20.6 full-time equivalents.8
Company details
Identity
- Enterprise number
- 0501.631.837
- VAT number
- BE 0501.631.837
- Peppol ID
- 0208:0501631837
- LEI code
- 984500D5DAEA3C774U19 live in the LEI register
- Legal form
- Public limited company
- Status
- Active, normal situation
- Founded
- 29-11-2012
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Thursday of Junedeed of 04-06-2026 (in French)
- General meeting ruleThe articles set who calls the general meeting, who may attend and how it decides.
- “Tout actionnaire peut se faire représenter à l'assemblée générale des actionnaires par un mandataire, actionnaire ou non. Les procurations…”“A l'exception des décisions qui doivent être passées par un acte authentique, les actionnaires peuvent, à l'unanimité, prendre par écrit…”deed of 04-06-2026 (in French)
- Website
- www.oncodna.com
- Peppol
- Reachable since 20-11-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- OncoDNA in French
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 04-06-2026 (in French)
Activities
NACEBEL 2025VAT activities
86910
Medical imaging and medical laboratories main activity
Social security (RSZ) activities
86910
Medical imaging and medical laboratories main activity
Joint committees annual accounts 2025
JC 330
Health institutions and services
Codes under NACEBEL 2008
VAT activities
86901
Human health activities main activity
Social security (RSZ) activities
86901
Human health activities main activity
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Toute prestation généralement quelconque de biologie moléculaire et notamment d'analyse génétique de tumeurs; La recherche, la conception…”deed of 04-06-2026 (in French)
8 activities
- Toute prestation généralement quelconque de biologie moléculaire et notamment d'analyse génétique de tumeurs
- La recherche, la conception, le développement, la fabrication et la commercialisation de tous produits ainsi que la prestation de tous services dans les domaines décrits ci-avant
- La commercialisation de procédés industriels sous quelque forme que ce soit
- La production, la promotion, l'achat et la vente, la sous-traitance, l’importation, l'exportation en gros, demi-gros ou en détail, la représentation et la maintenance dans les domaines précités
- Les services professionnels, la consultance, le parrainage et le partenariat dans les objets qui précèdent
- Le dépôt et l'exploitation des brevets, dessins et modèles, marques et autres droits intellectuels et patrimoniaux issus des objets qui précèdent
- La formation, l'information, la publication et l'édition sur tous supports en relation avec les objets qui précèdent
- La recherche, l'étude, la conception, l'achat et la vente de tous types d'appareillages et accessoires nécessaires à la fabrication, la transformation, la conservation et l'utilisation des produits précités
Registered office and establishments
1 establishment| Establishment | Since | Unit number |
|---|---|---|
| Rue Louis Breguet 1 registered office 6041 Charleroi | 09-07-2013 | 2.220.215.281 |
Contact
E-mail
corporate@oncodna.com